<html><head><meta content="text/html; charset=UTF-8" http-equiv="content-type"><style type="text/css">ol.lst-kix_dfpsym14kryb-6.start{counter-reset:lst-ctn-kix_dfpsym14kryb-6 0}ol.lst-kix_ayojtcncjfer-0.start{counter-reset:lst-ctn-kix_ayojtcncjfer-0 0}ol.lst-kix_8loxybkfotvz-1.start{counter-reset:lst-ctn-kix_8loxybkfotvz-1 0}.lst-kix_dfpsym14kryb-4>li{counter-increment:lst-ctn-kix_dfpsym14kryb-4}ol.lst-kix_eghtax1wt4z8-0.start{counter-reset:lst-ctn-kix_eghtax1wt4z8-0 0}.lst-kix_8loxybkfotvz-8>li{counter-increment:lst-ctn-kix_8loxybkfotvz-8}.lst-kix_ropu40jmzrdh-3>li{counter-increment:lst-ctn-kix_ropu40jmzrdh-3}.lst-kix_lv360auemu3h-2>li{counter-increment:lst-ctn-kix_lv360auemu3h-2}.lst-kix_nf9zt7o88e56-1>li:before{content:"\0025cb  "}.lst-kix_nf9zt7o88e56-0>li:before{content:"\0025cf  "}.lst-kix_nf9zt7o88e56-2>li:before{content:"\0025a0  "}.lst-kix_3on6cjd6ejif-2>li{counter-increment:lst-ctn-kix_3on6cjd6ejif-2}ol.lst-kix_dfpsym14kryb-2{list-style-type:none}.lst-kix_nf9zt7o88e56-5>li:before{content:"\0025a0  "}ol.lst-kix_dfpsym14kryb-1{list-style-type:none}.lst-kix_nf9zt7o88e56-4>li:before{content:"\0025cb  "}ol.lst-kix_dfpsym14kryb-0{list-style-type:none}ol.lst-kix_z9mazreum7w0-1.start{counter-reset:lst-ctn-kix_z9mazreum7w0-1 0}.lst-kix_nf9zt7o88e56-3>li:before{content:"\0025cf  "}ol.lst-kix_lv360auemu3h-2{list-style-type:none}.lst-kix_nf9zt7o88e56-6>li:before{content:"\0025cf  "}.lst-kix_nf9zt7o88e56-7>li:before{content:"\0025cb  "}ol.lst-kix_lv360auemu3h-3{list-style-type:none}.lst-kix_jtd3tbs1bw4z-1>li{counter-increment:lst-ctn-kix_jtd3tbs1bw4z-1}ol.lst-kix_lv360auemu3h-0{list-style-type:none}ol.lst-kix_lv360auemu3h-1{list-style-type:none}ol.lst-kix_lv360auemu3h-6{list-style-type:none}ol.lst-kix_lv360auemu3h-7{list-style-type:none}ol.lst-kix_lv360auemu3h-4{list-style-type:none}ol.lst-kix_dfpsym14kryb-1.start{counter-reset:lst-ctn-kix_dfpsym14kryb-1 0}ol.lst-kix_dfpsym14kryb-8{list-style-type:none}ol.lst-kix_lv360auemu3h-5{list-style-type:none}ol.lst-kix_dfpsym14kryb-7{list-style-type:none}ol.lst-kix_dfpsym14kryb-6{list-style-type:none}ol.lst-kix_jtd3tbs1bw4z-7.start{counter-reset:lst-ctn-kix_jtd3tbs1bw4z-7 0}ol.lst-kix_dfpsym14kryb-5{list-style-type:none}ol.lst-kix_lv360auemu3h-8{list-style-type:none}ol.lst-kix_dfpsym14kryb-4{list-style-type:none}ol.lst-kix_dfpsym14kryb-3{list-style-type:none}.lst-kix_dfpsym14kryb-8>li{counter-increment:lst-ctn-kix_dfpsym14kryb-8}.lst-kix_ayojtcncjfer-5>li{counter-increment:lst-ctn-kix_ayojtcncjfer-5}ul.lst-kix_3tdll8m5nog-8{list-style-type:none}ul.lst-kix_3tdll8m5nog-7{list-style-type:none}ol.lst-kix_l1zr2qb3o8je-5.start{counter-reset:lst-ctn-kix_l1zr2qb3o8je-5 0}.lst-kix_nf9zt7o88e56-8>li:before{content:"\0025a0  "}ul.lst-kix_3tdll8m5nog-6{list-style-type:none}ul.lst-kix_3tdll8m5nog-5{list-style-type:none}.lst-kix_wyrnpsmejgna-6>li:before{content:"\0025cf  "}ul.lst-kix_3tdll8m5nog-4{list-style-type:none}ul.lst-kix_3tdll8m5nog-3{list-style-type:none}ul.lst-kix_3tdll8m5nog-2{list-style-type:none}ol.lst-kix_8loxybkfotvz-6.start{counter-reset:lst-ctn-kix_8loxybkfotvz-6 0}ul.lst-kix_3tdll8m5nog-1{list-style-type:none}.lst-kix_wyrnpsmejgna-5>li:before{content:"\0025a0  "}ul.lst-kix_3tdll8m5nog-0{list-style-type:none}ol.lst-kix_z9mazreum7w0-8.start{counter-reset:lst-ctn-kix_z9mazreum7w0-8 0}.lst-kix_z9mazreum7w0-2>li{counter-increment:lst-ctn-kix_z9mazreum7w0-2}.lst-kix_wyrnpsmejgna-2>li:before{content:"\0025a0  "}.lst-kix_wyrnpsmejgna-4>li:before{content:"\0025cb  "}.lst-kix_wyrnpsmejgna-3>li:before{content:"\0025cf  "}ol.lst-kix_ayojtcncjfer-5.start{counter-reset:lst-ctn-kix_ayojtcncjfer-5 0}.lst-kix_wyrnpsmejgna-0>li:before{content:"\0025cf  "}.lst-kix_wyrnpsmejgna-1>li:before{content:"\0025cb  "}.lst-kix_l1zr2qb3o8je-2>li{counter-increment:lst-ctn-kix_l1zr2qb3o8je-2}ol.lst-kix_3on6cjd6ejif-7.start{counter-reset:lst-ctn-kix_3on6cjd6ejif-7 0}.lst-kix_l1zr2qb3o8je-5>li{counter-increment:lst-ctn-kix_l1zr2qb3o8je-5}ol.lst-kix_3on6cjd6ejif-0.start{counter-reset:lst-ctn-kix_3on6cjd6ejif-0 0}ol.lst-kix_eghtax1wt4z8-5.start{counter-reset:lst-ctn-kix_eghtax1wt4z8-5 0}ol.lst-kix_lv360auemu3h-7.start{counter-reset:lst-ctn-kix_lv360auemu3h-7 0}ol.lst-kix_l1zr2qb3o8je-0.start{counter-reset:lst-ctn-kix_l1zr2qb3o8je-0 0}.lst-kix_wyrnpsmejgna-7>li:before{content:"\0025cb  "}ol.lst-kix_ropu40jmzrdh-5.start{counter-reset:lst-ctn-kix_ropu40jmzrdh-5 0}.lst-kix_l0hhxagkhkxi-6>li{counter-increment:lst-ctn-kix_l0hhxagkhkxi-6}.lst-kix_wyrnpsmejgna-8>li:before{content:"\0025a0  "}ol.lst-kix_lv360auemu3h-0.start{counter-reset:lst-ctn-kix_lv360auemu3h-0 0}ol.lst-kix_l0hhxagkhkxi-6.start{counter-reset:lst-ctn-kix_l0hhxagkhkxi-6 0}.lst-kix_ayojtcncjfer-2>li{counter-increment:lst-ctn-kix_ayojtcncjfer-2}ol.lst-kix_jtd3tbs1bw4z-0.start{counter-reset:lst-ctn-kix_jtd3tbs1bw4z-0 0}ol.lst-kix_l1zr2qb3o8je-7.start{counter-reset:lst-ctn-kix_l1zr2qb3o8je-7 0}.lst-kix_jtd3tbs1bw4z-5>li{counter-increment:lst-ctn-kix_jtd3tbs1bw4z-5}ol.lst-kix_3on6cjd6ejif-3{list-style-type:none}ol.lst-kix_3on6cjd6ejif-2{list-style-type:none}ol.lst-kix_3on6cjd6ejif-1{list-style-type:none}ol.lst-kix_3on6cjd6ejif-0{list-style-type:none}ol.lst-kix_3on6cjd6ejif-7{list-style-type:none}.lst-kix_8loxybkfotvz-5>li{counter-increment:lst-ctn-kix_8loxybkfotvz-5}ol.lst-kix_3on6cjd6ejif-6{list-style-type:none}ol.lst-kix_3on6cjd6ejif-5{list-style-type:none}ul.lst-kix_jgnv5gsi5z2j-8{list-style-type:none}ol.lst-kix_3on6cjd6ejif-4{list-style-type:none}ul.lst-kix_jgnv5gsi5z2j-7{list-style-type:none}ul.lst-kix_jgnv5gsi5z2j-6{list-style-type:none}ul.lst-kix_jgnv5gsi5z2j-5{list-style-type:none}ul.lst-kix_jgnv5gsi5z2j-4{list-style-type:none}ul.lst-kix_jgnv5gsi5z2j-3{list-style-type:none}ul.lst-kix_jgnv5gsi5z2j-2{list-style-type:none}ol.lst-kix_3on6cjd6ejif-5.start{counter-reset:lst-ctn-kix_3on6cjd6ejif-5 0}ul.lst-kix_jgnv5gsi5z2j-1{list-style-type:none}.lst-kix_l1zr2qb3o8je-1>li{counter-increment:lst-ctn-kix_l1zr2qb3o8je-1}ul.lst-kix_jgnv5gsi5z2j-0{list-style-type:none}.lst-kix_jtd3tbs1bw4z-4>li{counter-increment:lst-ctn-kix_jtd3tbs1bw4z-4}ol.lst-kix_3on6cjd6ejif-2.start{counter-reset:lst-ctn-kix_3on6cjd6ejif-2 0}.lst-kix_eghtax1wt4z8-2>li{counter-increment:lst-ctn-kix_eghtax1wt4z8-2}.lst-kix_idda1uopvzix-1>li:before{content:"\0025cb  "}.lst-kix_lv360auemu3h-0>li:before{content:"" counter(lst-ctn-kix_lv360auemu3h-0,decimal) ". "}.lst-kix_idda1uopvzix-3>li:before{content:"\0025cf  "}.lst-kix_idda1uopvzix-5>li:before{content:"\0025a0  "}.lst-kix_eghtax1wt4z8-8>li:before{content:"" counter(lst-ctn-kix_eghtax1wt4z8-8,lower-roman) ". "}.lst-kix_lv360auemu3h-6>li:before{content:"" counter(lst-ctn-kix_lv360auemu3h-6,decimal) ". "}ol.lst-kix_3on6cjd6ejif-8{list-style-type:none}ol.lst-kix_ropu40jmzrdh-7.start{counter-reset:lst-ctn-kix_ropu40jmzrdh-7 0}.lst-kix_lv360auemu3h-8>li:before{content:"" counter(lst-ctn-kix_lv360auemu3h-8,lower-roman) ". "}.lst-kix_idda1uopvzix-7>li:before{content:"\0025cb  "}.lst-kix_eghtax1wt4z8-1>li{counter-increment:lst-ctn-kix_eghtax1wt4z8-1}ol.lst-kix_ayojtcncjfer-2.start{counter-reset:lst-ctn-kix_ayojtcncjfer-2 0}.lst-kix_l1zr2qb3o8je-6>li{counter-increment:lst-ctn-kix_l1zr2qb3o8je-6}ol.lst-kix_eghtax1wt4z8-7.start{counter-reset:lst-ctn-kix_eghtax1wt4z8-7 0}.lst-kix_3tdll8m5nog-8>li:before{content:"\0025a0  "}.lst-kix_9pa7v49w8h61-1>li:before{content:"\0025cb  "}.lst-kix_z9mazreum7w0-3>li{counter-increment:lst-ctn-kix_z9mazreum7w0-3}ol.lst-kix_jtd3tbs1bw4z-2.start{counter-reset:lst-ctn-kix_jtd3tbs1bw4z-2 0}.lst-kix_9pa7v49w8h61-3>li:before{content:"\0025cf  "}.lst-kix_3tdll8m5nog-6>li:before{content:"\0025cf  "}.lst-kix_3tdll8m5nog-0>li:before{content:"\0025cf  "}.lst-kix_9pa7v49w8h61-7>li:before{content:"\0025cb  "}.lst-kix_lv360auemu3h-4>li:before{content:"" counter(lst-ctn-kix_lv360auemu3h-4,lower-latin) ". "}ol.lst-kix_l0hhxagkhkxi-8.start{counter-reset:lst-ctn-kix_l0hhxagkhkxi-8 0}.lst-kix_3tdll8m5nog-4>li:before{content:"\0025cb  "}.lst-kix_lv360auemu3h-2>li:before{content:"" counter(lst-ctn-kix_lv360auemu3h-2,lower-roman) ". "}.lst-kix_8loxybkfotvz-4>li{counter-increment:lst-ctn-kix_8loxybkfotvz-4}ol.lst-kix_ropu40jmzrdh-8.start{counter-reset:lst-ctn-kix_ropu40jmzrdh-8 0}.lst-kix_9pa7v49w8h61-5>li:before{content:"\0025a0  "}.lst-kix_3tdll8m5nog-2>li:before{content:"\0025a0  "}.lst-kix_3on6cjd6ejif-3>li{counter-increment:lst-ctn-kix_3on6cjd6ejif-3}ol.lst-kix_8loxybkfotvz-8.start{counter-reset:lst-ctn-kix_8loxybkfotvz-8 0}.lst-kix_dfpsym14kryb-6>li:before{content:"" counter(lst-ctn-kix_dfpsym14kryb-6,decimal) ". "}ol.lst-kix_lv360auemu3h-3.start{counter-reset:lst-ctn-kix_lv360auemu3h-3 0}.lst-kix_ayojtcncjfer-8>li{counter-increment:lst-ctn-kix_ayojtcncjfer-8}.lst-kix_jgnv5gsi5z2j-0>li:before{content:"\0025cf  "}.lst-kix_dfpsym14kryb-3>li:before{content:"" counter(lst-ctn-kix_dfpsym14kryb-3,decimal) ". "}.lst-kix_dfpsym14kryb-7>li:before{content:"" counter(lst-ctn-kix_dfpsym14kryb-7,lower-latin) ". "}.lst-kix_dfpsym14kryb-2>li:before{content:"" counter(lst-ctn-kix_dfpsym14kryb-2,lower-roman) ". "}.lst-kix_z9mazreum7w0-0>li:before{content:"" counter(lst-ctn-kix_z9mazreum7w0-0,decimal) ". "}.lst-kix_z9mazreum7w0-7>li:before{content:"" counter(lst-ctn-kix_z9mazreum7w0-7,lower-latin) ". "}.lst-kix_z9mazreum7w0-8>li:before{content:"" counter(lst-ctn-kix_z9mazreum7w0-8,lower-roman) ". "}.lst-kix_dfpsym14kryb-5>li{counter-increment:lst-ctn-kix_dfpsym14kryb-5}.lst-kix_l0hhxagkhkxi-5>li{counter-increment:lst-ctn-kix_l0hhxagkhkxi-5}ul.lst-kix_f2z71wooa743-8{list-style-type:none}.lst-kix_z9mazreum7w0-5>li{counter-increment:lst-ctn-kix_z9mazreum7w0-5}.lst-kix_4gne5gp2bb3o-6>li:before{content:"\0025cf  "}.lst-kix_jgnv5gsi5z2j-6>li:before{content:"\0025cf  "}ul.lst-kix_f2z71wooa743-7{list-style-type:none}ul.lst-kix_f2z71wooa743-6{list-style-type:none}ul.lst-kix_f2z71wooa743-5{list-style-type:none}.lst-kix_4gne5gp2bb3o-7>li:before{content:"\0025cb  "}.lst-kix_jgnv5gsi5z2j-7>li:before{content:"\0025cb  "}ul.lst-kix_f2z71wooa743-0{list-style-type:none}ol.lst-kix_8loxybkfotvz-4.start{counter-reset:lst-ctn-kix_8loxybkfotvz-4 0}ul.lst-kix_f2z71wooa743-4{list-style-type:none}.lst-kix_z9mazreum7w0-3>li:before{content:"" counter(lst-ctn-kix_z9mazreum7w0-3,decimal) ". "}.lst-kix_z9mazreum7w0-4>li:before{content:"" counter(lst-ctn-kix_z9mazreum7w0-4,lower-latin) ". "}ul.lst-kix_f2z71wooa743-3{list-style-type:none}ul.lst-kix_f2z71wooa743-2{list-style-type:none}ul.lst-kix_f2z71wooa743-1{list-style-type:none}.lst-kix_f2z71wooa743-7>li:before{content:"\0025cb  "}.lst-kix_l0hhxagkhkxi-7>li{counter-increment:lst-ctn-kix_l0hhxagkhkxi-7}.lst-kix_3on6cjd6ejif-5>li{counter-increment:lst-ctn-kix_3on6cjd6ejif-5}ol.lst-kix_jtd3tbs1bw4z-4.start{counter-reset:lst-ctn-kix_jtd3tbs1bw4z-4 0}.lst-kix_dfpsym14kryb-7>li{counter-increment:lst-ctn-kix_dfpsym14kryb-7}.lst-kix_f2z71wooa743-6>li:before{content:"\0025cf  "}ol.lst-kix_eghtax1wt4z8-3.start{counter-reset:lst-ctn-kix_eghtax1wt4z8-3 0}ol.lst-kix_lv360auemu3h-8.start{counter-reset:lst-ctn-kix_lv360auemu3h-8 0}.lst-kix_f2z71wooa743-3>li:before{content:"\0025cf  "}.lst-kix_eghtax1wt4z8-6>li:before{content:"" counter(lst-ctn-kix_eghtax1wt4z8-6,decimal) ". "}.lst-kix_f2z71wooa743-2>li:before{content:"\0025a0  "}ol.lst-kix_ropu40jmzrdh-2{list-style-type:none}.lst-kix_eghtax1wt4z8-5>li:before{content:"" counter(lst-ctn-kix_eghtax1wt4z8-5,lower-roman) ". "}ol.lst-kix_ropu40jmzrdh-3{list-style-type:none}ol.lst-kix_3on6cjd6ejif-8.start{counter-reset:lst-ctn-kix_3on6cjd6ejif-8 0}ol.lst-kix_ropu40jmzrdh-4{list-style-type:none}ol.lst-kix_ropu40jmzrdh-5{list-style-type:none}ol.lst-kix_ropu40jmzrdh-6{list-style-type:none}.lst-kix_z9mazreum7w0-7>li{counter-increment:lst-ctn-kix_z9mazreum7w0-7}ol.lst-kix_ropu40jmzrdh-7{list-style-type:none}ol.lst-kix_ropu40jmzrdh-8{list-style-type:none}.lst-kix_eghtax1wt4z8-1>li:before{content:"" counter(lst-ctn-kix_eghtax1wt4z8-1,lower-latin) ". "}ol.lst-kix_eghtax1wt4z8-4.start{counter-reset:lst-ctn-kix_eghtax1wt4z8-4 0}ol.lst-kix_dfpsym14kryb-8.start{counter-reset:lst-ctn-kix_dfpsym14kryb-8 0}.lst-kix_l0hhxagkhkxi-8>li:before{content:"" counter(lst-ctn-kix_l0hhxagkhkxi-8,lower-roman) ". "}.lst-kix_eghtax1wt4z8-2>li:before{content:"" counter(lst-ctn-kix_eghtax1wt4z8-2,lower-roman) ". "}.lst-kix_3on6cjd6ejif-7>li{counter-increment:lst-ctn-kix_3on6cjd6ejif-7}ol.lst-kix_ropu40jmzrdh-0{list-style-type:none}ol.lst-kix_jtd3tbs1bw4z-5.start{counter-reset:lst-ctn-kix_jtd3tbs1bw4z-5 0}.lst-kix_l0hhxagkhkxi-7>li:before{content:"" counter(lst-ctn-kix_l0hhxagkhkxi-7,lower-latin) ". "}ol.lst-kix_ropu40jmzrdh-1{list-style-type:none}ol.lst-kix_dfpsym14kryb-4.start{counter-reset:lst-ctn-kix_dfpsym14kryb-4 0}.lst-kix_3on6cjd6ejif-5>li:before{content:"" counter(lst-ctn-kix_3on6cjd6ejif-5,lower-roman) ". "}.lst-kix_8loxybkfotvz-0>li{counter-increment:lst-ctn-kix_8loxybkfotvz-0}.lst-kix_jtd3tbs1bw4z-7>li:before{content:"" counter(lst-ctn-kix_jtd3tbs1bw4z-7,lower-latin) ". "}.lst-kix_jtd3tbs1bw4z-8>li:before{content:"" counter(lst-ctn-kix_jtd3tbs1bw4z-8,lower-roman) ". "}.lst-kix_ropu40jmzrdh-2>li{counter-increment:lst-ctn-kix_ropu40jmzrdh-2}.lst-kix_l0hhxagkhkxi-4>li:before{content:"" counter(lst-ctn-kix_l0hhxagkhkxi-4,lower-latin) ". "}.lst-kix_ropu40jmzrdh-0>li:before{content:"" counter(lst-ctn-kix_ropu40jmzrdh-0,decimal) ". "}.lst-kix_3on6cjd6ejif-6>li:before{content:"" counter(lst-ctn-kix_3on6cjd6ejif-6,decimal) ". "}.lst-kix_l0hhxagkhkxi-3>li:before{content:"" counter(lst-ctn-kix_l0hhxagkhkxi-3,decimal) ". "}ol.lst-kix_l0hhxagkhkxi-4.start{counter-reset:lst-ctn-kix_l0hhxagkhkxi-4 0}.lst-kix_jtd3tbs1bw4z-0>li:before{content:"" counter(lst-ctn-kix_jtd3tbs1bw4z-0,decimal) ". "}.lst-kix_l1zr2qb3o8je-8>li{counter-increment:lst-ctn-kix_l1zr2qb3o8je-8}.lst-kix_jtd3tbs1bw4z-3>li:before{content:"" counter(lst-ctn-kix_jtd3tbs1bw4z-3,decimal) ". "}.lst-kix_jtd3tbs1bw4z-4>li:before{content:"" counter(lst-ctn-kix_jtd3tbs1bw4z-4,lower-latin) ". "}.lst-kix_l0hhxagkhkxi-0>li:before{content:"" counter(lst-ctn-kix_l0hhxagkhkxi-0,decimal) ". "}.lst-kix_eghtax1wt4z8-3>li{counter-increment:lst-ctn-kix_eghtax1wt4z8-3}ol.lst-kix_dfpsym14kryb-3.start{counter-reset:lst-ctn-kix_dfpsym14kryb-3 0}ol.lst-kix_8loxybkfotvz-5.start{counter-reset:lst-ctn-kix_8loxybkfotvz-5 0}ol.lst-kix_l0hhxagkhkxi-5.start{counter-reset:lst-ctn-kix_l0hhxagkhkxi-5 0}.lst-kix_l0hhxagkhkxi-0>li{counter-increment:lst-ctn-kix_l0hhxagkhkxi-0}.lst-kix_eghtax1wt4z8-5>li{counter-increment:lst-ctn-kix_eghtax1wt4z8-5}.lst-kix_l1zr2qb3o8je-2>li:before{content:"" counter(lst-ctn-kix_l1zr2qb3o8je-2,lower-roman) ". "}ol.lst-kix_jtd3tbs1bw4z-6.start{counter-reset:lst-ctn-kix_jtd3tbs1bw4z-6 0}ol.lst-kix_eghtax1wt4z8-2.start{counter-reset:lst-ctn-kix_eghtax1wt4z8-2 0}.lst-kix_l1zr2qb3o8je-6>li:before{content:"" counter(lst-ctn-kix_l1zr2qb3o8je-6,decimal) ". "}.lst-kix_l1zr2qb3o8je-3>li{counter-increment:lst-ctn-kix_l1zr2qb3o8je-3}.lst-kix_lv360auemu3h-5>li{counter-increment:lst-ctn-kix_lv360auemu3h-5}ol.lst-kix_l0hhxagkhkxi-0.start{counter-reset:lst-ctn-kix_l0hhxagkhkxi-0 0}.lst-kix_ropu40jmzrdh-8>li:before{content:"" counter(lst-ctn-kix_ropu40jmzrdh-8,lower-roman) ". "}ol.lst-kix_dfpsym14kryb-7.start{counter-reset:lst-ctn-kix_dfpsym14kryb-7 0}.lst-kix_1qb3ubekxfb5-0>li:before{content:"\0025cf  "}.lst-kix_1qb3ubekxfb5-4>li:before{content:"\0025cb  "}ol.lst-kix_dfpsym14kryb-5.start{counter-reset:lst-ctn-kix_dfpsym14kryb-5 0}ol.lst-kix_lv360auemu3h-2.start{counter-reset:lst-ctn-kix_lv360auemu3h-2 0}.lst-kix_3on6cjd6ejif-2>li:before{content:"" counter(lst-ctn-kix_3on6cjd6ejif-2,lower-roman) ". "}.lst-kix_8loxybkfotvz-2>li{counter-increment:lst-ctn-kix_8loxybkfotvz-2}.lst-kix_bxaiij9jxv4a-0>li:before{content:"\0025cf  "}.lst-kix_l0hhxagkhkxi-2>li{counter-increment:lst-ctn-kix_l0hhxagkhkxi-2}ol.lst-kix_l0hhxagkhkxi-3.start{counter-reset:lst-ctn-kix_l0hhxagkhkxi-3 0}.lst-kix_m7ug533nwn28-1>li:before{content:"\0025cb  "}ol.lst-kix_8loxybkfotvz-0.start{counter-reset:lst-ctn-kix_8loxybkfotvz-0 0}ol.lst-kix_lv360auemu3h-5.start{counter-reset:lst-ctn-kix_lv360auemu3h-5 0}ol.lst-kix_8loxybkfotvz-3.start{counter-reset:lst-ctn-kix_8loxybkfotvz-3 0}.lst-kix_ayojtcncjfer-1>li{counter-increment:lst-ctn-kix_ayojtcncjfer-1}.lst-kix_ropu40jmzrdh-4>li:before{content:"" counter(lst-ctn-kix_ropu40jmzrdh-4,lower-latin) ". "}.lst-kix_ropu40jmzrdh-0>li{counter-increment:lst-ctn-kix_ropu40jmzrdh-0}.lst-kix_idda1uopvzix-2>li:before{content:"\0025a0  "}.lst-kix_m7ug533nwn28-5>li:before{content:"\0025a0  "}.lst-kix_szyv2fwd9a7b-2>li:before{content:"\0025a0  "}.lst-kix_bxaiij9jxv4a-8>li:before{content:"\0025a0  "}ol.lst-kix_l0hhxagkhkxi-1.start{counter-reset:lst-ctn-kix_l0hhxagkhkxi-1 0}.lst-kix_ropu40jmzrdh-7>li{counter-increment:lst-ctn-kix_ropu40jmzrdh-7}.lst-kix_8loxybkfotvz-7>li{counter-increment:lst-ctn-kix_8loxybkfotvz-7}.lst-kix_idda1uopvzix-6>li:before{content:"\0025cf  "}ol.lst-kix_eghtax1wt4z8-1.start{counter-reset:lst-ctn-kix_eghtax1wt4z8-1 0}.lst-kix_bxaiij9jxv4a-4>li:before{content:"\0025cb  "}.lst-kix_lv360auemu3h-5>li:before{content:"" counter(lst-ctn-kix_lv360auemu3h-5,lower-roman) ". "}.lst-kix_1qb3ubekxfb5-8>li:before{content:"\0025a0  "}.lst-kix_jtd3tbs1bw4z-8>li{counter-increment:lst-ctn-kix_jtd3tbs1bw4z-8}.lst-kix_7a6gagn5vckd-5>li:before{content:"\0025a0  "}.lst-kix_ayojtcncjfer-6>li{counter-increment:lst-ctn-kix_ayojtcncjfer-6}.lst-kix_8loxybkfotvz-7>li:before{content:"" counter(lst-ctn-kix_8loxybkfotvz-7,lower-latin) ". "}.lst-kix_szyv2fwd9a7b-6>li:before{content:"\0025cf  "}ol.lst-kix_jtd3tbs1bw4z-8.start{counter-reset:lst-ctn-kix_jtd3tbs1bw4z-8 0}.lst-kix_lc38j5mfc7uf-5>li:before{content:"\0025a0  "}ul.lst-kix_lc38j5mfc7uf-1{list-style-type:none}ul.lst-kix_lc38j5mfc7uf-0{list-style-type:none}.lst-kix_3tdll8m5nog-7>li:before{content:"\0025cb  "}ol.lst-kix_lv360auemu3h-4.start{counter-reset:lst-ctn-kix_lv360auemu3h-4 0}ul.lst-kix_lc38j5mfc7uf-3{list-style-type:none}ol.lst-kix_8loxybkfotvz-2.start{counter-reset:lst-ctn-kix_8loxybkfotvz-2 0}ul.lst-kix_lc38j5mfc7uf-2{list-style-type:none}.lst-kix_z9mazreum7w0-0>li{counter-increment:lst-ctn-kix_z9mazreum7w0-0}.lst-kix_9pa7v49w8h61-0>li:before{content:"\0025cf  "}.lst-kix_9pa7v49w8h61-4>li:before{content:"\0025cb  "}ol.lst-kix_l0hhxagkhkxi-2.start{counter-reset:lst-ctn-kix_l0hhxagkhkxi-2 0}ul.lst-kix_lc38j5mfc7uf-8{list-style-type:none}ul.lst-kix_lc38j5mfc7uf-5{list-style-type:none}.lst-kix_lc38j5mfc7uf-1>li:before{content:"\0025cb  "}ul.lst-kix_lc38j5mfc7uf-4{list-style-type:none}.lst-kix_ayojtcncjfer-6>li:before{content:"" counter(lst-ctn-kix_ayojtcncjfer-6,decimal) ". "}ul.lst-kix_lc38j5mfc7uf-7{list-style-type:none}ul.lst-kix_lc38j5mfc7uf-6{list-style-type:none}.lst-kix_dfpsym14kryb-0>li{counter-increment:lst-ctn-kix_dfpsym14kryb-0}.lst-kix_3on6cjd6ejif-0>li{counter-increment:lst-ctn-kix_3on6cjd6ejif-0}.lst-kix_8loxybkfotvz-3>li:before{content:"" counter(lst-ctn-kix_8loxybkfotvz-3,decimal) ". "}.lst-kix_4gne5gp2bb3o-3>li:before{content:"\0025cf  "}.lst-kix_7a6gagn5vckd-1>li:before{content:"\0025cb  "}.lst-kix_jgnv5gsi5z2j-3>li:before{content:"\0025cf  "}.lst-kix_9pa7v49w8h61-8>li:before{content:"\0025a0  "}.lst-kix_3tdll8m5nog-3>li:before{content:"\0025cf  "}.lst-kix_ayojtcncjfer-2>li:before{content:"" counter(lst-ctn-kix_ayojtcncjfer-2,lower-roman) ". "}.lst-kix_lv360auemu3h-1>li:before{content:"" counter(lst-ctn-kix_lv360auemu3h-1,lower-latin) ". "}ol.lst-kix_eghtax1wt4z8-6.start{counter-reset:lst-ctn-kix_eghtax1wt4z8-6 0}ol.lst-kix_ayojtcncjfer-8{list-style-type:none}.lst-kix_z9mazreum7w0-4>li{counter-increment:lst-ctn-kix_z9mazreum7w0-4}ol.lst-kix_ayojtcncjfer-7{list-style-type:none}.lst-kix_3on6cjd6ejif-4>li{counter-increment:lst-ctn-kix_3on6cjd6ejif-4}.lst-kix_lv360auemu3h-0>li{counter-increment:lst-ctn-kix_lv360auemu3h-0}ol.lst-kix_z9mazreum7w0-7.start{counter-reset:lst-ctn-kix_z9mazreum7w0-7 0}.lst-kix_eghtax1wt4z8-0>li{counter-increment:lst-ctn-kix_eghtax1wt4z8-0}ol.lst-kix_lv360auemu3h-6.start{counter-reset:lst-ctn-kix_lv360auemu3h-6 0}ol.lst-kix_3on6cjd6ejif-6.start{counter-reset:lst-ctn-kix_3on6cjd6ejif-6 0}.lst-kix_ropu40jmzrdh-5>li{counter-increment:lst-ctn-kix_ropu40jmzrdh-5}ol.lst-kix_l0hhxagkhkxi-7.start{counter-reset:lst-ctn-kix_l0hhxagkhkxi-7 0}ol.lst-kix_ayojtcncjfer-6.start{counter-reset:lst-ctn-kix_ayojtcncjfer-6 0}ol.lst-kix_8loxybkfotvz-7.start{counter-reset:lst-ctn-kix_8loxybkfotvz-7 0}.lst-kix_ayojtcncjfer-7>li{counter-increment:lst-ctn-kix_ayojtcncjfer-7}ul.lst-kix_9pa7v49w8h61-0{list-style-type:none}ul.lst-kix_nf9zt7o88e56-8{list-style-type:none}ul.lst-kix_9pa7v49w8h61-3{list-style-type:none}ul.lst-kix_9pa7v49w8h61-4{list-style-type:none}ol.lst-kix_3on6cjd6ejif-1.start{counter-reset:lst-ctn-kix_3on6cjd6ejif-1 0}ul.lst-kix_nf9zt7o88e56-6{list-style-type:none}ul.lst-kix_9pa7v49w8h61-1{list-style-type:none}ul.lst-kix_nf9zt7o88e56-7{list-style-type:none}ul.lst-kix_9pa7v49w8h61-2{list-style-type:none}ul.lst-kix_nf9zt7o88e56-4{list-style-type:none}ul.lst-kix_9pa7v49w8h61-7{list-style-type:none}ul.lst-kix_nf9zt7o88e56-5{list-style-type:none}ul.lst-kix_9pa7v49w8h61-8{list-style-type:none}ul.lst-kix_nf9zt7o88e56-2{list-style-type:none}ul.lst-kix_9pa7v49w8h61-5{list-style-type:none}ul.lst-kix_nf9zt7o88e56-3{list-style-type:none}ul.lst-kix_9pa7v49w8h61-6{list-style-type:none}ul.lst-kix_nf9zt7o88e56-0{list-style-type:none}.lst-kix_dfpsym14kryb-2>li{counter-increment:lst-ctn-kix_dfpsym14kryb-2}ul.lst-kix_nf9zt7o88e56-1{list-style-type:none}ol.lst-kix_l1zr2qb3o8je-1.start{counter-reset:lst-ctn-kix_l1zr2qb3o8je-1 0}.lst-kix_8loxybkfotvz-6>li{counter-increment:lst-ctn-kix_8loxybkfotvz-6}ol.lst-kix_lv360auemu3h-1.start{counter-reset:lst-ctn-kix_lv360auemu3h-1 0}ol.lst-kix_z9mazreum7w0-2.start{counter-reset:lst-ctn-kix_z9mazreum7w0-2 0}.lst-kix_z9mazreum7w0-8>li{counter-increment:lst-ctn-kix_z9mazreum7w0-8}ol.lst-kix_ropu40jmzrdh-4.start{counter-reset:lst-ctn-kix_ropu40jmzrdh-4 0}.lst-kix_jtd3tbs1bw4z-3>li{counter-increment:lst-ctn-kix_jtd3tbs1bw4z-3}.lst-kix_jtd3tbs1bw4z-6>li{counter-increment:lst-ctn-kix_jtd3tbs1bw4z-6}ol.lst-kix_l1zr2qb3o8je-6.start{counter-reset:lst-ctn-kix_l1zr2qb3o8je-6 0}.lst-kix_lv360auemu3h-7>li{counter-increment:lst-ctn-kix_lv360auemu3h-7}ol.lst-kix_ayojtcncjfer-4{list-style-type:none}ol.lst-kix_ayojtcncjfer-3{list-style-type:none}ol.lst-kix_ayojtcncjfer-6{list-style-type:none}ol.lst-kix_ayojtcncjfer-5{list-style-type:none}ol.lst-kix_ayojtcncjfer-0{list-style-type:none}ol.lst-kix_ayojtcncjfer-2{list-style-type:none}.lst-kix_lv360auemu3h-4>li{counter-increment:lst-ctn-kix_lv360auemu3h-4}ol.lst-kix_ayojtcncjfer-1{list-style-type:none}ol.lst-kix_jtd3tbs1bw4z-3.start{counter-reset:lst-ctn-kix_jtd3tbs1bw4z-3 0}.lst-kix_l1zr2qb3o8je-1>li:before{content:"" counter(lst-ctn-kix_l1zr2qb3o8je-1,lower-latin) ". "}ol.lst-kix_ropu40jmzrdh-6.start{counter-reset:lst-ctn-kix_ropu40jmzrdh-6 0}.lst-kix_8loxybkfotvz-3>li{counter-increment:lst-ctn-kix_8loxybkfotvz-3}.lst-kix_l1zr2qb3o8je-5>li:before{content:"" counter(lst-ctn-kix_l1zr2qb3o8je-5,lower-roman) ". "}.lst-kix_l1zr2qb3o8je-3>li:before{content:"" counter(lst-ctn-kix_l1zr2qb3o8je-3,decimal) ". "}.lst-kix_l1zr2qb3o8je-7>li:before{content:"" counter(lst-ctn-kix_l1zr2qb3o8je-7,lower-latin) ". "}ol.lst-kix_z9mazreum7w0-0.start{counter-reset:lst-ctn-kix_z9mazreum7w0-0 0}.lst-kix_ayojtcncjfer-3>li{counter-increment:lst-ctn-kix_ayojtcncjfer-3}ol.lst-kix_dfpsym14kryb-2.start{counter-reset:lst-ctn-kix_dfpsym14kryb-2 0}.lst-kix_1qb3ubekxfb5-1>li:before{content:"\0025cb  "}.lst-kix_lv360auemu3h-8>li{counter-increment:lst-ctn-kix_lv360auemu3h-8}.lst-kix_3on6cjd6ejif-8>li{counter-increment:lst-ctn-kix_3on6cjd6ejif-8}.lst-kix_1qb3ubekxfb5-3>li:before{content:"\0025cf  "}.lst-kix_ropu40jmzrdh-7>li:before{content:"" counter(lst-ctn-kix_ropu40jmzrdh-7,lower-latin) ". "}.lst-kix_3on6cjd6ejif-1>li:before{content:"" counter(lst-ctn-kix_3on6cjd6ejif-1,lower-latin) ". "}.lst-kix_3on6cjd6ejif-3>li:before{content:"" counter(lst-ctn-kix_3on6cjd6ejif-3,decimal) ". "}.lst-kix_ropu40jmzrdh-1>li:before{content:"" counter(lst-ctn-kix_ropu40jmzrdh-1,lower-latin) ". "}.lst-kix_bxaiij9jxv4a-1>li:before{content:"\0025cb  "}ul.lst-kix_1qb3ubekxfb5-8{list-style-type:none}.lst-kix_ayojtcncjfer-4>li{counter-increment:lst-ctn-kix_ayojtcncjfer-4}ul.lst-kix_1qb3ubekxfb5-7{list-style-type:none}.lst-kix_m7ug533nwn28-0>li:before{content:"\0025cf  "}ul.lst-kix_1qb3ubekxfb5-6{list-style-type:none}ul.lst-kix_1qb3ubekxfb5-5{list-style-type:none}ul.lst-kix_1qb3ubekxfb5-4{list-style-type:none}.lst-kix_ropu40jmzrdh-3>li:before{content:"" counter(lst-ctn-kix_ropu40jmzrdh-3,decimal) ". "}ul.lst-kix_1qb3ubekxfb5-3{list-style-type:none}.lst-kix_m7ug533nwn28-2>li:before{content:"\0025a0  "}ul.lst-kix_1qb3ubekxfb5-2{list-style-type:none}ul.lst-kix_1qb3ubekxfb5-1{list-style-type:none}ul.lst-kix_1qb3ubekxfb5-0{list-style-type:none}.lst-kix_ropu40jmzrdh-5>li:before{content:"" counter(lst-ctn-kix_ropu40jmzrdh-5,lower-roman) ". "}.lst-kix_szyv2fwd9a7b-3>li:before{content:"\0025cf  "}ol.lst-kix_jtd3tbs1bw4z-1{list-style-type:none}.lst-kix_m7ug533nwn28-6>li:before{content:"\0025cf  "}ol.lst-kix_jtd3tbs1bw4z-2{list-style-type:none}.lst-kix_eghtax1wt4z8-8>li{counter-increment:lst-ctn-kix_eghtax1wt4z8-8}ol.lst-kix_jtd3tbs1bw4z-0{list-style-type:none}ul.lst-kix_4gne5gp2bb3o-8{list-style-type:none}ol.lst-kix_jtd3tbs1bw4z-5{list-style-type:none}ul.lst-kix_4gne5gp2bb3o-7{list-style-type:none}.lst-kix_m7ug533nwn28-4>li:before{content:"\0025cb  "}ol.lst-kix_jtd3tbs1bw4z-6{list-style-type:none}ol.lst-kix_jtd3tbs1bw4z-3{list-style-type:none}ol.lst-kix_jtd3tbs1bw4z-4{list-style-type:none}ol.lst-kix_jtd3tbs1bw4z-1.start{counter-reset:lst-ctn-kix_jtd3tbs1bw4z-1 0}.lst-kix_szyv2fwd9a7b-1>li:before{content:"\0025cb  "}.lst-kix_bxaiij9jxv4a-3>li:before{content:"\0025cf  "}.lst-kix_7a6gagn5vckd-2>li:before{content:"\0025a0  "}.lst-kix_lc38j5mfc7uf-8>li:before{content:"\0025a0  "}.lst-kix_l1zr2qb3o8je-7>li{counter-increment:lst-ctn-kix_l1zr2qb3o8je-7}.lst-kix_7a6gagn5vckd-4>li:before{content:"\0025cb  "}.lst-kix_lc38j5mfc7uf-6>li:before{content:"\0025cf  "}.lst-kix_l1zr2qb3o8je-0>li{counter-increment:lst-ctn-kix_l1zr2qb3o8je-0}.lst-kix_1qb3ubekxfb5-7>li:before{content:"\0025cb  "}.lst-kix_lv360auemu3h-3>li{counter-increment:lst-ctn-kix_lv360auemu3h-3}.lst-kix_8loxybkfotvz-6>li:before{content:"" counter(lst-ctn-kix_8loxybkfotvz-6,decimal) ". "}.lst-kix_szyv2fwd9a7b-7>li:before{content:"\0025cb  "}.lst-kix_1qb3ubekxfb5-5>li:before{content:"\0025a0  "}.lst-kix_bxaiij9jxv4a-5>li:before{content:"\0025a0  "}.lst-kix_7a6gagn5vckd-8>li:before{content:"\0025a0  "}.lst-kix_m7ug533nwn28-8>li:before{content:"\0025a0  "}.lst-kix_l0hhxagkhkxi-4>li{counter-increment:lst-ctn-kix_l0hhxagkhkxi-4}.lst-kix_8loxybkfotvz-8>li:before{content:"" counter(lst-ctn-kix_8loxybkfotvz-8,lower-roman) ". "}.lst-kix_szyv2fwd9a7b-5>li:before{content:"\0025a0  "}.lst-kix_bxaiij9jxv4a-7>li:before{content:"\0025cb  "}.lst-kix_7a6gagn5vckd-6>li:before{content:"\0025cf  "}.lst-kix_lc38j5mfc7uf-4>li:before{content:"\0025cb  "}.lst-kix_eghtax1wt4z8-7>li{counter-increment:lst-ctn-kix_eghtax1wt4z8-7}.lst-kix_ayojtcncjfer-5>li:before{content:"" counter(lst-ctn-kix_ayojtcncjfer-5,lower-roman) ". "}ol.lst-kix_dfpsym14kryb-0.start{counter-reset:lst-ctn-kix_dfpsym14kryb-0 0}.lst-kix_4gne5gp2bb3o-0>li:before{content:"\0025cf  "}.lst-kix_lc38j5mfc7uf-2>li:before{content:"\0025a0  "}.lst-kix_8loxybkfotvz-4>li:before{content:"" counter(lst-ctn-kix_8loxybkfotvz-4,lower-latin) ". "}.lst-kix_ayojtcncjfer-7>li:before{content:"" counter(lst-ctn-kix_ayojtcncjfer-7,lower-latin) ". "}ol.lst-kix_3on6cjd6ejif-4.start{counter-reset:lst-ctn-kix_3on6cjd6ejif-4 0}.lst-kix_lc38j5mfc7uf-0>li:before{content:"\0025cf  "}.lst-kix_8loxybkfotvz-2>li:before{content:"" counter(lst-ctn-kix_8loxybkfotvz-2,lower-roman) ". "}.lst-kix_dfpsym14kryb-3>li{counter-increment:lst-ctn-kix_dfpsym14kryb-3}.lst-kix_4gne5gp2bb3o-4>li:before{content:"\0025cb  "}.lst-kix_jgnv5gsi5z2j-4>li:before{content:"\0025cb  "}ol.lst-kix_eghtax1wt4z8-8.start{counter-reset:lst-ctn-kix_eghtax1wt4z8-8 0}.lst-kix_ayojtcncjfer-1>li:before{content:"" counter(lst-ctn-kix_ayojtcncjfer-1,lower-latin) ". "}.lst-kix_4gne5gp2bb3o-2>li:before{content:"\0025a0  "}.lst-kix_7a6gagn5vckd-0>li:before{content:"\0025cf  "}.lst-kix_jgnv5gsi5z2j-2>li:before{content:"\0025a0  "}ol.lst-kix_jtd3tbs1bw4z-7{list-style-type:none}ol.lst-kix_jtd3tbs1bw4z-8{list-style-type:none}.lst-kix_8loxybkfotvz-0>li:before{content:"" counter(lst-ctn-kix_8loxybkfotvz-0,decimal) ". "}.lst-kix_ayojtcncjfer-3>li:before{content:"" counter(lst-ctn-kix_ayojtcncjfer-3,decimal) ". "}ol.lst-kix_ayojtcncjfer-1.start{counter-reset:lst-ctn-kix_ayojtcncjfer-1 0}.lst-kix_z9mazreum7w0-5>li:before{content:"" counter(lst-ctn-kix_z9mazreum7w0-5,lower-roman) ". "}.lst-kix_z9mazreum7w0-6>li:before{content:"" counter(lst-ctn-kix_z9mazreum7w0-6,decimal) ". "}.lst-kix_dfpsym14kryb-5>li:before{content:"" counter(lst-ctn-kix_dfpsym14kryb-5,lower-roman) ". "}.lst-kix_z9mazreum7w0-1>li:before{content:"" counter(lst-ctn-kix_z9mazreum7w0-1,lower-latin) ". "}.lst-kix_dfpsym14kryb-1>li:before{content:"" counter(lst-ctn-kix_dfpsym14kryb-1,lower-latin) ". "}.lst-kix_ropu40jmzrdh-4>li{counter-increment:lst-ctn-kix_ropu40jmzrdh-4}.lst-kix_dfpsym14kryb-0>li:before{content:"" counter(lst-ctn-kix_dfpsym14kryb-0,decimal) ". "}.lst-kix_dfpsym14kryb-8>li:before{content:"" counter(lst-ctn-kix_dfpsym14kryb-8,lower-roman) ". "}ol.lst-kix_ropu40jmzrdh-2.start{counter-reset:lst-ctn-kix_ropu40jmzrdh-2 0}ol.lst-kix_eghtax1wt4z8-1{list-style-type:none}ol.lst-kix_eghtax1wt4z8-0{list-style-type:none}ol.lst-kix_eghtax1wt4z8-3{list-style-type:none}.lst-kix_4gne5gp2bb3o-8>li:before{content:"\0025a0  "}ol.lst-kix_eghtax1wt4z8-2{list-style-type:none}.lst-kix_jgnv5gsi5z2j-8>li:before{content:"\0025a0  "}ol.lst-kix_eghtax1wt4z8-5{list-style-type:none}ol.lst-kix_eghtax1wt4z8-4{list-style-type:none}ol.lst-kix_3on6cjd6ejif-3.start{counter-reset:lst-ctn-kix_3on6cjd6ejif-3 0}ol.lst-kix_eghtax1wt4z8-7{list-style-type:none}.lst-kix_z9mazreum7w0-2>li:before{content:"" counter(lst-ctn-kix_z9mazreum7w0-2,lower-roman) ". "}ol.lst-kix_eghtax1wt4z8-6{list-style-type:none}ol.lst-kix_eghtax1wt4z8-8{list-style-type:none}ol.lst-kix_8loxybkfotvz-7{list-style-type:none}ol.lst-kix_8loxybkfotvz-8{list-style-type:none}.lst-kix_f2z71wooa743-8>li:before{content:"\0025a0  "}ol.lst-kix_8loxybkfotvz-5{list-style-type:none}ol.lst-kix_8loxybkfotvz-6{list-style-type:none}ol.lst-kix_z9mazreum7w0-4.start{counter-reset:lst-ctn-kix_z9mazreum7w0-4 0}.lst-kix_ropu40jmzrdh-6>li{counter-increment:lst-ctn-kix_ropu40jmzrdh-6}ol.lst-kix_8loxybkfotvz-0{list-style-type:none}.lst-kix_f2z71wooa743-4>li:before{content:"\0025cb  "}ol.lst-kix_8loxybkfotvz-3{list-style-type:none}ol.lst-kix_8loxybkfotvz-4{list-style-type:none}ol.lst-kix_ayojtcncjfer-3.start{counter-reset:lst-ctn-kix_ayojtcncjfer-3 0}.lst-kix_f2z71wooa743-5>li:before{content:"\0025a0  "}ol.lst-kix_8loxybkfotvz-1{list-style-type:none}ol.lst-kix_8loxybkfotvz-2{list-style-type:none}.lst-kix_f2z71wooa743-0>li:before{content:"\0025cf  "}ul.lst-kix_4gne5gp2bb3o-4{list-style-type:none}ul.lst-kix_4gne5gp2bb3o-3{list-style-type:none}ul.lst-kix_4gne5gp2bb3o-6{list-style-type:none}ol.lst-kix_l1zr2qb3o8je-8.start{counter-reset:lst-ctn-kix_l1zr2qb3o8je-8 0}ul.lst-kix_4gne5gp2bb3o-5{list-style-type:none}ul.lst-kix_4gne5gp2bb3o-0{list-style-type:none}.lst-kix_f2z71wooa743-1>li:before{content:"\0025cb  "}.lst-kix_dfpsym14kryb-4>li:before{content:"" counter(lst-ctn-kix_dfpsym14kryb-4,lower-latin) ". "}ul.lst-kix_4gne5gp2bb3o-2{list-style-type:none}ul.lst-kix_4gne5gp2bb3o-1{list-style-type:none}ul.lst-kix_7a6gagn5vckd-5{list-style-type:none}.lst-kix_eghtax1wt4z8-4>li:before{content:"" counter(lst-ctn-kix_eghtax1wt4z8-4,lower-latin) ". "}ul.lst-kix_7a6gagn5vckd-6{list-style-type:none}ul.lst-kix_7a6gagn5vckd-3{list-style-type:none}ul.lst-kix_bxaiij9jxv4a-1{list-style-type:none}ul.lst-kix_7a6gagn5vckd-4{list-style-type:none}ul.lst-kix_bxaiij9jxv4a-0{list-style-type:none}ul.lst-kix_bxaiij9jxv4a-3{list-style-type:none}.lst-kix_eghtax1wt4z8-3>li:before{content:"" counter(lst-ctn-kix_eghtax1wt4z8-3,decimal) ". "}ul.lst-kix_bxaiij9jxv4a-2{list-style-type:none}.lst-kix_3on6cjd6ejif-1>li{counter-increment:lst-ctn-kix_3on6cjd6ejif-1}ul.lst-kix_7a6gagn5vckd-7{list-style-type:none}ul.lst-kix_bxaiij9jxv4a-5{list-style-type:none}.lst-kix_l0hhxagkhkxi-3>li{counter-increment:lst-ctn-kix_l0hhxagkhkxi-3}ul.lst-kix_7a6gagn5vckd-8{list-style-type:none}ul.lst-kix_bxaiij9jxv4a-4{list-style-type:none}ol.lst-kix_l0hhxagkhkxi-1{list-style-type:none}.lst-kix_eghtax1wt4z8-0>li:before{content:"" counter(lst-ctn-kix_eghtax1wt4z8-0,decimal) ". "}ol.lst-kix_l0hhxagkhkxi-0{list-style-type:none}.lst-kix_l0hhxagkhkxi-6>li:before{content:"" counter(lst-ctn-kix_l0hhxagkhkxi-6,decimal) ". "}.lst-kix_z9mazreum7w0-1>li{counter-increment:lst-ctn-kix_z9mazreum7w0-1}ul.lst-kix_m7ug533nwn28-0{list-style-type:none}.lst-kix_3on6cjd6ejif-4>li:before{content:"" counter(lst-ctn-kix_3on6cjd6ejif-4,lower-latin) ". "}ul.lst-kix_m7ug533nwn28-1{list-style-type:none}ul.lst-kix_m7ug533nwn28-2{list-style-type:none}.lst-kix_l0hhxagkhkxi-2>li:before{content:"" counter(lst-ctn-kix_l0hhxagkhkxi-2,lower-roman) ". "}ul.lst-kix_m7ug533nwn28-3{list-style-type:none}ul.lst-kix_m7ug533nwn28-4{list-style-type:none}.lst-kix_jtd3tbs1bw4z-5>li:before{content:"" counter(lst-ctn-kix_jtd3tbs1bw4z-5,lower-roman) ". "}.lst-kix_jtd3tbs1bw4z-6>li:before{content:"" counter(lst-ctn-kix_jtd3tbs1bw4z-6,decimal) ". "}ul.lst-kix_m7ug533nwn28-5{list-style-type:none}ul.lst-kix_szyv2fwd9a7b-0{list-style-type:none}ul.lst-kix_m7ug533nwn28-6{list-style-type:none}.lst-kix_l0hhxagkhkxi-1>li:before{content:"" counter(lst-ctn-kix_l0hhxagkhkxi-1,lower-latin) ". "}.lst-kix_l0hhxagkhkxi-5>li:before{content:"" counter(lst-ctn-kix_l0hhxagkhkxi-5,lower-roman) ". "}ul.lst-kix_m7ug533nwn28-7{list-style-type:none}ul.lst-kix_szyv2fwd9a7b-2{list-style-type:none}ul.lst-kix_m7ug533nwn28-8{list-style-type:none}.lst-kix_3on6cjd6ejif-8>li:before{content:"" counter(lst-ctn-kix_3on6cjd6ejif-8,lower-roman) ". "}ul.lst-kix_szyv2fwd9a7b-1{list-style-type:none}ul.lst-kix_szyv2fwd9a7b-4{list-style-type:none}ul.lst-kix_szyv2fwd9a7b-3{list-style-type:none}ul.lst-kix_szyv2fwd9a7b-6{list-style-type:none}ul.lst-kix_7a6gagn5vckd-1{list-style-type:none}.lst-kix_ropu40jmzrdh-8>li{counter-increment:lst-ctn-kix_ropu40jmzrdh-8}.lst-kix_3on6cjd6ejif-7>li:before{content:"" counter(lst-ctn-kix_3on6cjd6ejif-7,lower-latin) ". "}ul.lst-kix_szyv2fwd9a7b-5{list-style-type:none}ul.lst-kix_7a6gagn5vckd-2{list-style-type:none}ul.lst-kix_szyv2fwd9a7b-8{list-style-type:none}.lst-kix_dfpsym14kryb-1>li{counter-increment:lst-ctn-kix_dfpsym14kryb-1}ul.lst-kix_szyv2fwd9a7b-7{list-style-type:none}ul.lst-kix_7a6gagn5vckd-0{list-style-type:none}.lst-kix_jtd3tbs1bw4z-0>li{counter-increment:lst-ctn-kix_jtd3tbs1bw4z-0}.lst-kix_jtd3tbs1bw4z-1>li:before{content:"" counter(lst-ctn-kix_jtd3tbs1bw4z-1,lower-latin) ". "}.lst-kix_jtd3tbs1bw4z-2>li:before{content:"" counter(lst-ctn-kix_jtd3tbs1bw4z-2,lower-roman) ". "}.lst-kix_l1zr2qb3o8je-8>li:before{content:"" counter(lst-ctn-kix_l1zr2qb3o8je-8,lower-roman) ". "}.lst-kix_eghtax1wt4z8-6>li{counter-increment:lst-ctn-kix_eghtax1wt4z8-6}ul.lst-kix_wyrnpsmejgna-8{list-style-type:none}ul.lst-kix_wyrnpsmejgna-5{list-style-type:none}ul.lst-kix_wyrnpsmejgna-4{list-style-type:none}ol.lst-kix_l0hhxagkhkxi-8{list-style-type:none}ul.lst-kix_wyrnpsmejgna-7{list-style-type:none}ol.lst-kix_ayojtcncjfer-4.start{counter-reset:lst-ctn-kix_ayojtcncjfer-4 0}ol.lst-kix_l0hhxagkhkxi-7{list-style-type:none}ul.lst-kix_wyrnpsmejgna-6{list-style-type:none}ol.lst-kix_l0hhxagkhkxi-6{list-style-type:none}ul.lst-kix_wyrnpsmejgna-1{list-style-type:none}ol.lst-kix_l0hhxagkhkxi-5{list-style-type:none}ul.lst-kix_wyrnpsmejgna-0{list-style-type:none}ol.lst-kix_l0hhxagkhkxi-4{list-style-type:none}ul.lst-kix_wyrnpsmejgna-3{list-style-type:none}ol.lst-kix_l0hhxagkhkxi-3{list-style-type:none}ul.lst-kix_wyrnpsmejgna-2{list-style-type:none}ol.lst-kix_l0hhxagkhkxi-2{list-style-type:none}.lst-kix_lv360auemu3h-1>li{counter-increment:lst-ctn-kix_lv360auemu3h-1}ol.lst-kix_l1zr2qb3o8je-8{list-style-type:none}ol.lst-kix_l1zr2qb3o8je-7{list-style-type:none}ol.lst-kix_ayojtcncjfer-7.start{counter-reset:lst-ctn-kix_ayojtcncjfer-7 0}ol.lst-kix_l1zr2qb3o8je-6{list-style-type:none}.lst-kix_l1zr2qb3o8je-0>li:before{content:"" counter(lst-ctn-kix_l1zr2qb3o8je-0,decimal) ". "}ol.lst-kix_z9mazreum7w0-3.start{counter-reset:lst-ctn-kix_z9mazreum7w0-3 0}.lst-kix_l1zr2qb3o8je-4>li:before{content:"" counter(lst-ctn-kix_l1zr2qb3o8je-4,lower-latin) ". "}.lst-kix_lv360auemu3h-6>li{counter-increment:lst-ctn-kix_lv360auemu3h-6}ol.lst-kix_l1zr2qb3o8je-1{list-style-type:none}ol.lst-kix_l1zr2qb3o8je-0{list-style-type:none}.lst-kix_eghtax1wt4z8-4>li{counter-increment:lst-ctn-kix_eghtax1wt4z8-4}ol.lst-kix_l1zr2qb3o8je-5{list-style-type:none}ol.lst-kix_l1zr2qb3o8je-4{list-style-type:none}ol.lst-kix_l1zr2qb3o8je-3{list-style-type:none}ol.lst-kix_l1zr2qb3o8je-2{list-style-type:none}.lst-kix_l0hhxagkhkxi-1>li{counter-increment:lst-ctn-kix_l0hhxagkhkxi-1}ol.lst-kix_l1zr2qb3o8je-4.start{counter-reset:lst-ctn-kix_l1zr2qb3o8je-4 0}.lst-kix_ropu40jmzrdh-6>li:before{content:"" counter(lst-ctn-kix_ropu40jmzrdh-6,decimal) ". "}ol.lst-kix_ropu40jmzrdh-3.start{counter-reset:lst-ctn-kix_ropu40jmzrdh-3 0}.lst-kix_ropu40jmzrdh-2>li:before{content:"" counter(lst-ctn-kix_ropu40jmzrdh-2,lower-roman) ". "}.lst-kix_1qb3ubekxfb5-2>li:before{content:"\0025a0  "}.lst-kix_bxaiij9jxv4a-2>li:before{content:"\0025a0  "}.lst-kix_l1zr2qb3o8je-4>li{counter-increment:lst-ctn-kix_l1zr2qb3o8je-4}ul.lst-kix_bxaiij9jxv4a-7{list-style-type:none}.lst-kix_jtd3tbs1bw4z-7>li{counter-increment:lst-ctn-kix_jtd3tbs1bw4z-7}ul.lst-kix_bxaiij9jxv4a-6{list-style-type:none}.lst-kix_3on6cjd6ejif-0>li:before{content:"" counter(lst-ctn-kix_3on6cjd6ejif-0,decimal) ". "}ul.lst-kix_bxaiij9jxv4a-8{list-style-type:none}.lst-kix_idda1uopvzix-0>li:before{content:"\0025cf  "}ol.lst-kix_ropu40jmzrdh-0.start{counter-reset:lst-ctn-kix_ropu40jmzrdh-0 0}ol.lst-kix_z9mazreum7w0-5.start{counter-reset:lst-ctn-kix_z9mazreum7w0-5 0}.lst-kix_szyv2fwd9a7b-4>li:before{content:"\0025cb  "}.lst-kix_m7ug533nwn28-3>li:before{content:"\0025cf  "}.lst-kix_m7ug533nwn28-7>li:before{content:"\0025cb  "}.lst-kix_eghtax1wt4z8-7>li:before{content:"" counter(lst-ctn-kix_eghtax1wt4z8-7,lower-latin) ". "}ul.lst-kix_idda1uopvzix-0{list-style-type:none}.lst-kix_szyv2fwd9a7b-0>li:before{content:"\0025cf  "}.lst-kix_szyv2fwd9a7b-8>li:before{content:"\0025a0  "}.lst-kix_idda1uopvzix-4>li:before{content:"\0025cb  "}.lst-kix_ropu40jmzrdh-1>li{counter-increment:lst-ctn-kix_ropu40jmzrdh-1}ol.lst-kix_z9mazreum7w0-8{list-style-type:none}ol.lst-kix_z9mazreum7w0-7{list-style-type:none}.lst-kix_7a6gagn5vckd-3>li:before{content:"\0025cf  "}.lst-kix_lc38j5mfc7uf-7>li:before{content:"\0025cb  "}ol.lst-kix_z9mazreum7w0-6{list-style-type:none}.lst-kix_l0hhxagkhkxi-8>li{counter-increment:lst-ctn-kix_l0hhxagkhkxi-8}ol.lst-kix_z9mazreum7w0-5{list-style-type:none}ol.lst-kix_z9mazreum7w0-4{list-style-type:none}.lst-kix_jtd3tbs1bw4z-2>li{counter-increment:lst-ctn-kix_jtd3tbs1bw4z-2}ol.lst-kix_z9mazreum7w0-3{list-style-type:none}ol.lst-kix_z9mazreum7w0-2{list-style-type:none}ol.lst-kix_ropu40jmzrdh-1.start{counter-reset:lst-ctn-kix_ropu40jmzrdh-1 0}.lst-kix_lv360auemu3h-7>li:before{content:"" counter(lst-ctn-kix_lv360auemu3h-7,lower-latin) ". "}ol.lst-kix_z9mazreum7w0-1{list-style-type:none}ol.lst-kix_l1zr2qb3o8je-2.start{counter-reset:lst-ctn-kix_l1zr2qb3o8je-2 0}.lst-kix_ayojtcncjfer-0>li{counter-increment:lst-ctn-kix_ayojtcncjfer-0}ol.lst-kix_z9mazreum7w0-0{list-style-type:none}ul.lst-kix_idda1uopvzix-2{list-style-type:none}ul.lst-kix_idda1uopvzix-1{list-style-type:none}.lst-kix_7a6gagn5vckd-7>li:before{content:"\0025cb  "}.lst-kix_lc38j5mfc7uf-3>li:before{content:"\0025cf  "}ul.lst-kix_idda1uopvzix-4{list-style-type:none}.lst-kix_bxaiij9jxv4a-6>li:before{content:"\0025cf  "}ul.lst-kix_idda1uopvzix-3{list-style-type:none}ul.lst-kix_idda1uopvzix-6{list-style-type:none}ul.lst-kix_idda1uopvzix-5{list-style-type:none}.lst-kix_idda1uopvzix-8>li:before{content:"\0025a0  "}ul.lst-kix_idda1uopvzix-8{list-style-type:none}.lst-kix_1qb3ubekxfb5-6>li:before{content:"\0025cf  "}ul.lst-kix_idda1uopvzix-7{list-style-type:none}ol.lst-kix_z9mazreum7w0-6.start{counter-reset:lst-ctn-kix_z9mazreum7w0-6 0}.lst-kix_ayojtcncjfer-4>li:before{content:"" counter(lst-ctn-kix_ayojtcncjfer-4,lower-latin) ". "}.lst-kix_ayojtcncjfer-8>li:before{content:"" counter(lst-ctn-kix_ayojtcncjfer-8,lower-roman) ". "}.lst-kix_z9mazreum7w0-6>li{counter-increment:lst-ctn-kix_z9mazreum7w0-6}ol.lst-kix_ayojtcncjfer-8.start{counter-reset:lst-ctn-kix_ayojtcncjfer-8 0}.lst-kix_8loxybkfotvz-5>li:before{content:"" counter(lst-ctn-kix_8loxybkfotvz-5,lower-roman) ". "}.lst-kix_3tdll8m5nog-5>li:before{content:"\0025a0  "}.lst-kix_9pa7v49w8h61-2>li:before{content:"\0025a0  "}.lst-kix_4gne5gp2bb3o-5>li:before{content:"\0025a0  "}.lst-kix_jgnv5gsi5z2j-5>li:before{content:"\0025a0  "}.lst-kix_8loxybkfotvz-1>li:before{content:"" counter(lst-ctn-kix_8loxybkfotvz-1,lower-latin) ". "}.lst-kix_3tdll8m5nog-1>li:before{content:"\0025cb  "}.lst-kix_ayojtcncjfer-0>li:before{content:"" counter(lst-ctn-kix_ayojtcncjfer-0,decimal) ". "}.lst-kix_lv360auemu3h-3>li:before{content:"" counter(lst-ctn-kix_lv360auemu3h-3,decimal) ". "}.lst-kix_4gne5gp2bb3o-1>li:before{content:"\0025cb  "}.lst-kix_jgnv5gsi5z2j-1>li:before{content:"\0025cb  "}ol.lst-kix_l1zr2qb3o8je-3.start{counter-reset:lst-ctn-kix_l1zr2qb3o8je-3 0}.lst-kix_3on6cjd6ejif-6>li{counter-increment:lst-ctn-kix_3on6cjd6ejif-6}.lst-kix_8loxybkfotvz-1>li{counter-increment:lst-ctn-kix_8loxybkfotvz-1}.lst-kix_dfpsym14kryb-6>li{counter-increment:lst-ctn-kix_dfpsym14kryb-6}.lst-kix_9pa7v49w8h61-6>li:before{content:"\0025cf  "}ol{margin:0;padding:0}table td,table th{padding:0}.c21{border-right-style:solid;padding-top:5pt;border-top-width:1pt;border-bottom-color:#000000;border-right-width:1pt;padding-left:5pt;border-left-color:#000000;padding-bottom:5pt;line-height:1.15;border-right-color:#000000;border-left-width:1pt;border-top-style:solid;background-color:#f3f3f3;border-left-style:solid;border-bottom-width:1pt;border-top-color:#000000;border-bottom-style:solid;orphans:2;widows:2;text-align:left;padding-right:5pt}.c40{background-color:#d9ead3;margin-left:18pt;padding-top:0pt;padding-left:0pt;padding-bottom:8pt;line-height:1.12;orphans:2;widows:2;text-align:left}.c31{background-color:#d9ead3;margin-left:18pt;padding-top:0pt;padding-left:0pt;padding-bottom:5pt;line-height:1.12;orphans:2;widows:2;text-align:left}.c38{background-color:#d9ead3;margin-left:18pt;padding-top:0pt;padding-left:0pt;padding-bottom:7pt;line-height:1.12;orphans:2;widows:2;text-align:left}.c33{background-color:#c9daf8;margin-left:18pt;padding-top:0pt;padding-left:0pt;padding-bottom:10pt;line-height:1.12;orphans:2;widows:2;text-align:left}.c30{background-color:#c9daf8;margin-left:18pt;padding-top:0pt;padding-left:0pt;padding-bottom:5pt;line-height:1.12;orphans:2;widows:2;text-align:left}.c8{padding-top:20pt;padding-bottom:6pt;line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left;height:20pt}.c45{padding-top:0pt;padding-bottom:3pt;line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.c26{color:#666666;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:12pt;font-family:"Arial";font-style:normal}.c32{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Arial";font-style:italic}.c17{padding-top:16pt;padding-bottom:4pt;line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.c24{margin-left:18pt;padding-top:3pt;padding-bottom:4pt;line-height:1.0;orphans:2;widows:2;text-align:left}.c0{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Arial";font-style:normal}.c18{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:16pt;font-family:"Arial";font-style:normal}.c42{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:26pt;font-family:"Arial";font-style:normal}.c27{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:20pt;font-family:"Arial";font-style:normal}.c19{padding-top:20pt;padding-bottom:6pt;line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.c13{padding-top:18pt;padding-bottom:6pt;line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.c25{padding-top:14pt;padding-bottom:4pt;line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.c15{margin-left:54pt;padding-top:3pt;padding-bottom:0pt;line-height:1.0;orphans:2;widows:2;text-align:left}.c5{margin-left:18pt;padding-top:3pt;padding-bottom:0pt;line-height:1.0;orphans:2;widows:2;text-align:left}.c3{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:left;height:11pt}.c11{color:#434343;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:14pt;font-family:"Arial";font-style:normal}.c4{margin-left:36pt;padding-top:3pt;padding-bottom:0pt;line-height:1.0;orphans:2;widows:2;text-align:left}.c23{color:#000000;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Arial";font-style:normal}.c37{padding-top:4pt;padding-bottom:0pt;line-height:1.0;orphans:2;widows:2;text-align:left}.c20{padding-top:0pt;padding-bottom:12pt;line-height:1.15;orphans:2;widows:2;text-align:left}.c7{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:left}.c12{padding-top:0pt;padding-bottom:10pt;line-height:1.13;orphans:2;widows:2;text-align:left}.c22{padding-top:10pt;padding-bottom:0pt;line-height:1.0;orphans:2;widows:2;text-align:left}.c43{font-weight:400;vertical-align:baseline;font-size:11pt;font-family:"Arial";font-style:normal}.c34{padding-top:0pt;padding-bottom:0pt;line-height:1.0;text-align:left}.c9{text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;text-decoration:underline}.c41{background-color:#ffffff;max-width:451.3pt;padding:72pt 72pt 72pt 72pt}.c39{color:#434343;font-size:14pt}.c14{padding:0;margin:0}.c2{color:inherit;text-decoration:inherit}.c16{margin-left:72pt;padding-left:0pt}.c1{font-size:18pt;font-weight:700}.c35{border:1px solid black;margin:5px}.c29{margin-left:108pt;padding-left:0pt}.c10{margin-left:36pt;padding-left:0pt}.c6{font-weight:700}.c36{font-style:italic}.c44{background-color:#c9daf8}.c46{background-color:#d9ead3}.c28{height:11pt}.title{padding-top:0pt;color:#000000;font-size:26pt;padding-bottom:3pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.subtitle{padding-top:0pt;color:#666666;font-size:15pt;padding-bottom:16pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}li{color:#000000;font-size:11pt;font-family:"Arial"}p{margin:0;color:#000000;font-size:11pt;font-family:"Arial"}h1{padding-top:20pt;color:#000000;font-size:20pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h2{padding-top:18pt;color:#000000;font-size:16pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h3{padding-top:16pt;color:#434343;font-size:14pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h4{padding-top:14pt;color:#666666;font-size:12pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h5{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h6{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;font-style:italic;orphans:2;widows:2;text-align:left}</style></head><body class="c41"><p class="c45 title" id="h.rkk47w3hwhjc"><span>AIDA </span><span>Data Sharing Policy</span></p><p class="c7"><span class="c0">Version: 1.0</span></p><p class="c7"><span class="c0">Approved: 2019-12-13</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Author: Joel Hedlund, Data director AIDA.</span></p><h1 class="c19" id="h.i8ha364iuxr6"><span class="c27">Preface</span></h1><p class="c7"><span>This document has been drawn up by </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida/&amp;sa=D&amp;ust=1576784591993000">AIDA</a></span><span class="c0">&nbsp;in order to provide succinct and understandable guidelines for its activities, and in an attempt to describe the common practice in ethical, legal and FAIR data sharing for AI in medical imaging diagnostics in Sweden. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>AIDA policies are set continuously by </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida/organisation/&amp;sa=D&amp;ust=1576784591994000">AIDA management</a></span><span class="c0">, who reports to the AIDA steering group.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>AIDA</span><span class="c0">&nbsp;is a collaboration arena for AI in medical image analysis, and is an initiative within the Strategic innovation program Medtech4Health, jointly supported by VINNOVA, Formas and the Swedish Energy Agency.</span></p><h1 class="c19" id="h.h919a89yv5uz"><span class="c27">Sections</span></h1><p class="c12"><span class="c9 c6"><a class="c2" href="#h.o07if1qjma1p">Context</a></span><span class="c0"><br>The ethical and legal context of AIDA, and an overview of the common practice in the use of clinical imaging data for research in Sweden and similar countries.</span></p><p class="c12"><span class="c9 c6"><a class="c2" href="#h.wbomzglh2rsl">AIDA data sharing</a></span><span class="c0"><br>Policies on data sharing in AIDA.</span></p><p class="c12"><span class="c9 c6"><a class="c2" href="#h.6t1pdq248vyk">Appendix 1</a></span><span class="c6">&nbsp;</span><span class="c0"><br>Discussion on the ethical and legal context of the common practice, with reference to law text in official sources.</span></p><p class="c12"><span class="c6 c9"><a class="c2" href="#h.jq11ducoq2g1">Appendix 2</a></span><span class="c6">&nbsp;</span><span class="c0"><br>Examples of language in ethical review applications to support data sharing.</span></p><p class="c12"><span class="c9 c6"><a class="c2" href="#h.y634q6va22h">Appendix 3</a></span><span class="c6">&nbsp;</span><span class="c0"><br>Examples of what AIDA considers correct anonymization in medical imaging.</span></p><h1 class="c19" id="h.7ywgfnc33dzm"><span class="c27">Disclaimer</span></h1><p class="c7"><span class="c0">This document does not constitute legal advice.</span></p><p class="c3"><span class="c0"></span></p><hr style="page-break-before:always;display:none;"><h1 class="c8" id="h.ouxt2ksdnmzk"><span class="c27"></span></h1><h1 class="c19" id="h.jxvqbgchf6bz"><span class="c27">Contents</span></h1><p class="c37"><span class="c23 c6"><a class="c2" href="#h.h919a89yv5uz">Sections</a></span><span class="c23 c6">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c23 c6"><a class="c2" href="#h.h919a89yv5uz">1</a></span></p><p class="c22"><span class="c23 c6"><a class="c2" href="#h.7ywgfnc33dzm">Disclaimer</a></span><span class="c23 c6">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c23 c6"><a class="c2" href="#h.7ywgfnc33dzm">1</a></span></p><p class="c22"><span class="c23 c6"><a class="c2" href="#h.jxvqbgchf6bz">Contents</a></span><span class="c23 c6">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c23 c6"><a class="c2" href="#h.jxvqbgchf6bz">2</a></span></p><p class="c22"><span class="c23 c6"><a class="c2" href="#h.o07if1qjma1p">Context</a></span><span class="c23 c6">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c23 c6"><a class="c2" href="#h.o07if1qjma1p">5</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.gi4cgl6sjilc">Common practice in the use of clinical imaging data for research in Sweden</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.gi4cgl6sjilc">5</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.yj4ewpf0zyau">Appropriate technical and organizational protective measures</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.yj4ewpf0zyau">6</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.izc9oajshdzf">General notes</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.izc9oajshdzf">6</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.ehd2n2d80dvr">Informational protective measures</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.ehd2n2d80dvr">7</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.2zdx4co9xlpx">Organizational protective measures</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.2zdx4co9xlpx">8</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.vhhin4v1sk1u">Technical protective measures</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.vhhin4v1sk1u">9</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.5eqhfrq5f4m2">Ethics and protective measures in research on clinical data</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.5eqhfrq5f4m2">9</a></span></p><p class="c22"><span class="c23 c6"><a class="c2" href="#h.g2on669tl3wd">AIDA data sharing</a></span><span class="c23 c6">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c23 c6"><a class="c2" href="#h.g2on669tl3wd">11</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.narguwpbdajr">Overview</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.narguwpbdajr">12</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.scwhib8fehup">Getting access</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.scwhib8fehup">13</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.7h4e0ukokja3">Personal data and legal basis</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.7h4e0ukokja3">13</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.wgbk2wn4v2tr">Roles</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.wgbk2wn4v2tr">13</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.mghk8xc1gise">Tools</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.mghk8xc1gise">14</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.6l9xvf91th8p">AIDA PACS</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.6l9xvf91th8p">14</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.wy3qtdodds44">File sharing</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.wy3qtdodds44">14</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.w5xq3lct75vd">Tools for large-scale data exports</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.w5xq3lct75vd">14</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.hlxrehmxegqn">AIDA data hub sharing</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.hlxrehmxegqn">14</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.h3cq089iumt4">AIDA dataset register</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.h3cq089iumt4">15</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.j4fejy63shai">Modes of access</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.j4fejy63shai">15</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.whe481t5b3jz">Scope and priorities</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.whe481t5b3jz">15</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.6oox52vnqj5l">Visibility, citability, and digital object identifiers</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.6oox52vnqj5l">16</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.sdomrkpb15ym">AIDA data sharing licenses</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.sdomrkpb15ym">16</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.hqqqco4ysz3j">AIDA license</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.hqqqco4ysz3j">16</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.ndofpje4mr7r">AIDA BY license</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.ndofpje4mr7r">17</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.4jzyr84k3cg7">AIDA CA license</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.4jzyr84k3cg7">18</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.bfbi57byl90q">AIDA BY CA license</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.bfbi57byl90q">18</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.9apftz6x3kl3">Large-scale data exports</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.9apftz6x3kl3">19</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.3bhcfaugzh1a">Selective sharing</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.3bhcfaugzh1a">19</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.twa5knd31zt8">Support to ethical review applications in research</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.twa5knd31zt8">20</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.451bq2n1myw">Facilitating data sharing outside of AIDA</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.451bq2n1myw">20</a></span></p><p class="c22"><span class="c23 c6"><a class="c2" href="#h.6t1pdq248vyk">Appendix 1 <br>Discussion on law, ethics and the common practice in the use of clinical imaging data for research in Sweden</a></span><span class="c23 c6">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c23 c6"><a class="c2" href="#h.6t1pdq248vyk">21</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.yqn6rdkzu3no">Data processing services, and the cloud</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.yqn6rdkzu3no">24</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.jqg9p3qlo7q">Protective measures</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.jqg9p3qlo7q">24</a></span></p><p class="c22"><span class="c23 c6"><a class="c2" href="#h.jq11ducoq2g1">Appendix 2 <br>Examples of language in ethical review applications to support data sharing in research</a></span><span class="c23 c6">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c23 c6"><a class="c2" href="#h.jq11ducoq2g1">27</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.jzyk2celmez6">Examples</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.jzyk2celmez6">27</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.if7j0qxngvl">Relevanta avdelningar</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.if7j0qxngvl">27</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.tbbf4snf6p9m">Datam&auml;ngder</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.tbbf4snf6p9m">28</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.mhbnsddbr895">Riskminimering</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.mhbnsddbr895">28</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.2obk3aa9o4c3">Sekretess</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.2obk3aa9o4c3">28</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.t84fyd663dl3">Ansvar och kompetens</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.t84fyd663dl3">29</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.qy9bkchn39xr">&Aring;tkomstbegr&auml;nsning</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.qy9bkchn39xr">29</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.l5z1t3cy3jeu">Begr&auml;nsning till mindre k&auml;nsliga datatyper</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.l5z1t3cy3jeu">29</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.k7lav71znfk7">Begr&auml;nsning till enbart data</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.k7lav71znfk7">29</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.n4iwafkgpm0e">Deltagande i flera projekt</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.n4iwafkgpm0e">29</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.jibkole80hrr">Teknik</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.jibkole80hrr">30</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.xvv4qloei5cv">L&auml;nkad data fr&aring;n flera k&auml;llor</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.xvv4qloei5cv">30</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.8nnz0gjxndct">Pseudonym data</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.8nnz0gjxndct">30</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.ywcb8xospw6v">Anonym data</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.ywcb8xospw6v">31</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.5qvu5ayuqaib">Examples translated to English</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.5qvu5ayuqaib">32</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.eilczfr0pu0z">Relevant sections</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.eilczfr0pu0z">32</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.fhffb6cyzrnq">Amounts of data</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.fhffb6cyzrnq">33</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.e57qzfkanu2l">Risk minimization</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.e57qzfkanu2l">33</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.15d0rtrlckol">Confidentiality</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.15d0rtrlckol">33</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.qs4spcfvr7o8">Responsibility and competence</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.qs4spcfvr7o8">34</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.7tuzijxm8i6s">Access restrictions</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.7tuzijxm8i6s">34</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.9jp564v8dj5m">Limitation to less sensitive data types</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.9jp564v8dj5m">34</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.509smevwfdbf">Limitation to only data</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.509smevwfdbf">34</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.z581szqivo61">Participation in multiple projects</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.z581szqivo61">34</a></span></p><p class="c15"><span class="c0"><a class="c2" href="#h.jrpc573v0rsp">Technology</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.jrpc573v0rsp">35</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.yg5m7zj2gakk">Linked data from several sources</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.yg5m7zj2gakk">35</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.30gszmslsd72">Pseudonymous data</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.30gszmslsd72">35</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.8r419tfng12h">Anonymous data</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.8r419tfng12h">36</a></span></p><p class="c22"><span class="c23 c6"><a class="c2" href="#h.g7csyqb0s5h5">Appendix 3 <br>Examples of anonymization in medical imaging</a></span><span class="c23 c6">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c23 c6"><a class="c2" href="#h.g7csyqb0s5h5">39</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.am9tnqromcqb">General guidelines</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.am9tnqromcqb">39</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.1zhfi8ui0l70">Associated information</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.1zhfi8ui0l70">39</a></span></p><p class="c4"><span class="c0"><a class="c2" href="#h.gi6nk6rt1ay1">Anonymization measures for clinical imaging data</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.gi6nk6rt1ay1">40</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.fkapetemf4d8">Computed Tomography Pulmonary Angiography (CTPA) data</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.fkapetemf4d8">40</a></span></p><p class="c5"><span class="c0"><a class="c2" href="#h.9uaduxcj7iyv">Skeletal data from the Visual Sweden project DROID</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.9uaduxcj7iyv">42</a></span></p><p class="c24"><span class="c0"><a class="c2" href="#h.cyo9t71vzsdg">Axillary lymph nodes in breast cancer cases</a></span><span class="c0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="c0"><a class="c2" href="#h.cyo9t71vzsdg">42</a></span></p><hr style="page-break-before:always;display:none;"><h1 class="c8" id="h.ik03d41mkkaz"><span class="c27"></span></h1><h1 class="c19" id="h.o07if1qjma1p"><span class="c27">Context</span></h1><p class="c7"><span>The most important enabler for world-class computational research in biomedicine is access to massive amounts of high-quality data. OpenScience and</span><span><a class="c2" href="https://www.google.com/url?q=https://www.go-fair.org/fair-principles/&amp;sa=D&amp;ust=1576784592039000">&nbsp;</a></span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.go-fair.org/fair-principles/&amp;sa=D&amp;ust=1576784592039000">FAIR</a></span><span>&nbsp;</span><span class="c0">data sharing are means to achieve this. However, despite detailed data protection guidelines and support functions, many of the implementational details are still left to the individual researcher to resolve, and effective data sharing is often hindered because of the resulting uncertainties.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://datasets.aida.medtech4health.se/&amp;sa=D&amp;ust=1576784592040000">AIDA data hub</a></span><span class="c0">&nbsp;has been established as a place where researchers can gather, annotate, share and enrich massive amounts of training data to support the development of artificial intelligence (AI) in medical image analysis, in a way that ensures regulatory compliance and where contributors can get increased exposure and credit for their work.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida/&amp;sa=D&amp;ust=1576784592041000">AIDA</a></span><span>&nbsp;</span><span class="c0">can also facilitate large scale exports for research from clinical production systems in medical imaging, and can cover costs for sharing prioritized data on the AIDA data hub. AIDA can also help researchers draft ethical review applications that include data sharing.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">This section relates AIDA decisions about its data sharing activities to what AIDA has identified as the common practice of using and sharing clinical imaging data for research in Sweden and similar countries.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>AIDA</span><span class="c0">&nbsp;is a collaboration arena for AI in medical image analysis. Here, academia, industry and healthcare meet in innovation projects to translate progress in technology into patient benefit in the form of AI tools that are directly useful in day-to-day clinical care.</span></p><h2 class="c13" id="h.gi4cgl6sjilc"><span class="c18">Common practice in the use of clinical imaging data for research in Sweden</span></h2><p class="c7"><span>The general data protection regulation (</span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%235&amp;sa=D&amp;ust=1576784592043000">GDPR</a></span><span class="c0">) regulates all processing of personal data in Europe. It however allows countries to adopt national legislation in specific well defined areas. Healthcare and research are two such areas.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>Clinical imaging data is typically collected to </span><span>provide care for patients</span><span>. Swedish patient data law (</span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/patientdatalag-2008355_sfs-2008-355%23K2P4&amp;sa=D&amp;ust=1576784592045000">PDL</a></span><span>) however</span><span>&nbsp;allows caregivers to also use it for other legally specified purposes if needed, for example for improving </span><span>quality</span><span class="c0">&nbsp;and safety of care, administration, planning, follow-up, evaluation, overseeing, and to produce healthcare statistics. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">GDPR also allows this data to be used for research, for example at universities or companies. The ethical/legal framework surrounding these activities is complex, however the take-home message is that most research is allowed, if only it can be properly motivated. (And the obvious corollary: if it cannot, then it is not). </span></p><p class="c3"><span class="c0"></span></p><hr style="page-break-before:always;display:none;"><p class="c3"><span class="c0"></span></p><p class="c7"><span>In brief, the common practice is that caregivers disclose data to research institutions for specific activities described in approved ethical review applications, to be carried out under appropriate technical and organizational protective measures and supervised by a named competent researcher. The research institution is then data controller and copyright holder for the disclosed data, and is responsible for ensuring that data is processed and shared only as described in the approved </span><span>ethical review application</span><span>, with data processing agreements, pseudonymization, anonymization and licensing as tools, and </span><span>(starting 2020-01-01)</span><sup><a href="#cmnt1" id="cmnt_ref1">[a]</a></sup><span class="c0">&nbsp;with an obligation to store relevant data for 10 years after last use for purposes of research validation.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">More on appropriate protective measures and ethics in the sections below.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c9"><a class="c2" href="#h.6t1pdq248vyk">Appendix 1</a></span><span>&nbsp;discusses t</span><span>he legal context around this common practice in further detail</span><span>, with reference to original sources</span><span class="c0">.</span></p><h2 class="c13" id="h.yj4ewpf0zyau"><span class="c18">Appropriate technical and organizational protective measures</span></h2><p class="c7"><span>As we can see in </span><span>Appendix 1 and its section on </span><span class="c9"><a class="c2" href="#h.jqg9p3qlo7q">Protective measures</a></span><span>, d</span><span class="c0">espite detailed data protection guidelines and support functions, many of the implementational details regarding how to properly protect personal data are still left to the individual researcher to resolve. This is to a large part due to the nature of research itself, whose mission it is to investigate the unclear and to learn the unknown, which makes it hard for anyone to usefully advise researchers on how to best protect the data that they themselves are the most intimately acquainted with and our foremost experts on.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Researchers can to some degree find support from data protection officers, institutional policies, and in policy documents such as this, and perhaps more in the approval of ethical review applications (that they themselves likely wrote!) but detailed questions like &quot;can this data be considered anonymous?&quot;, and &quot;are these protective measures appropriate?&quot; must by necessity be answered finally by the researchers themselves. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>There are however two encouraging consequences arising from this: while the ethical/legal framework surrounding these activities is complex, most research is actually allowed if only it can be properly motivated. And the obvious corollary: if it cannot, then it is not. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>More on this in the </span><span class="c9"><a class="c2" href="#h.5eqhfrq5f4m2">Ethics and protective measures in research on clinical data</a></span><span class="c0">&nbsp;section below.</span></p><h3 class="c17" id="h.izc9oajshdzf"><span>General notes</span></h3><p class="c7"><span class="c0">GDPR lists principles for protection, including purpose limitation (only for specified legal purposes), data minimization (only use relevant and necessary data), storage minimization (do not keep longer than necessary), and integrity and confidentiality (technical and organizational measures). It also suggests using encryption and pseudonymization when suitable. Also, GDPR requires that protective measures must be appropriate given state-of-the-art, and be followed up to ensure that this remains true over time.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">It is a good practice to review each processing step in the data flow all the way from source through research to archival for research validation, and look for opportunities to apply these principles and protective measures, taking care not to choose protective measures that hinder research activities that foreseeably could add significant value to individuals and society, such as data sharing to enable further research.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">For example: Must identifying data be sent, or is it possible to pseudonymize or even anonymize at the source? Can this data be anonymized for publications? Can this data be shared for further research? If it is pseudonymized? If it is anonymized? Do I really need all these different types of data to answer the research questions in this project, or could I do it with less?</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">But also: Are there more research questions I could potentially answer if I could get access to more types of data in the same extraction process, for example for ruling out that certain factors contribute to disease, and could that add significant value to individuals and society without significant increase in risk and effort? </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">And especially: At what points would it be possible for me to introduce protective measures that could significantly reduce risk without significantly hindering useful research?</span></p><h3 class="c17" id="h.ehd2n2d80dvr"><span>Informational </span><span class="c39">protective measures</span></h3><p class="c7"><span class="c0">It is very easy to protect data that no longer exists. These measures concern identifying points where data or parts of data can be pseudonymized, anonymized or even deleted. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Pseudonymization entails processing data so that it no longer can be attributed to a natural person, without the use of additional information (eg: a key) which is to be kept secret and separate. Anonymization entails deleting that key. It is nontrivial to assess the quality of pseudonymization/anonymization. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://docs.google.com/document/d/1TvjTeoUiqaafnBQGaJDjHcFCUBfhiKmUTWJG_bkGIWs/edit%23heading%3Dh.i639kmr8va6o&amp;sa=D&amp;ust=1576784592053000">AIDA definition of anonymous data</a></span><span>&nbsp;is described in AIDA GDPR policy 1.0. </span><span class="c9"><a class="c2" href="#h.y634q6va22h">Appendix 3</a></span><span>&nbsp;describes what AIDA considers correct anonymization in medical imaging using examples from the </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://datasets.aida.medtech4health.se/&amp;sa=D&amp;ust=1576784592054000">AIDA dataset register</a></span><span>&nbsp;along with rationale to support researchers trying to choose appropriate anonymization methods for their own datasets.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>Even in cases where an image is inarguably anonymous, it may still be potentially sensitive information and identifiable through its associated data, like diagnosis, lab analysis data, time stamps, patient age and sex and so on. This problem is not unique to the medical field, and a</span><span>&nbsp;lot of work has already been done to clarify how such data can be anonymized effectively. </span><span>The Finnish social science data archive have produced a very good guide on </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.fsd.uta.fi/aineistonhallinta/en/anonymisation-and-identifiers.html&amp;sa=D&amp;ust=1576784592055000">anonymization and personal data</a></span><span>&nbsp;in research, including </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.fsd.uta.fi/aineistonhallinta/en/anonymisation-and-identifiers.html%23bases-of-anonymisation&amp;sa=D&amp;ust=1576784592056000">anonymization techniques</a></span><span>&nbsp;(please search in-page)</span><span>.</span><span>&nbsp;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>Techniques </span><span>(please see the </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.fsd.uta.fi/aineistonhallinta/en/anonymisation-and-identifiers.html%23bases-of-anonymisation&amp;sa=D&amp;ust=1576784592057000">FSD guide on anonymization techniques</a></span><span>&nbsp;for details)</span><span>:</span></p><ol class="c14 lst-kix_3on6cjd6ejif-0 start" start="1"><li class="c20 c10"><span class="c6">Removing variables, values and units of observation</span><span class="c0">&nbsp;</span></li><li class="c20 c10"><span class="c6">Recoding variable values</span><span class="c0"><br>Specify region rather exact location, represent age not with birth date but as &quot;number of years&quot; or give as ranges appropriately large given the data, eg 1, 2-3, 4-6, 7-10, or 11+ years, etc...</span></li><li class="c20 c10"><span class="c6">Editing responses in open-ended variables</span><span class="c0">&nbsp;<br>Remove specific names, addresses etc in provided free-text information. Replace with [higher education], [sports], [identifier removed], etc...</span></li><li class="c20 c10"><span class="c6">K-anonymity and L-diversity</span><span class="c0">&nbsp;<br>Choose anonymization techniques that ensure that at least K (preferably at least 3, or 5-10) individuals are represented for each possible set of indirectly identifying attributes, and that there are at least L (preferably at least 2) values for each sensitive attribute. This ensures that specific sensitive characteristic cannot be attributed to an individual, or a whole group of similar individuals. </span></li><li class="c20 c10"><span class="c6">Noise addition</span><span class="c0">&nbsp;<br>Add small additive or proportional noise to numbers, like age, starting time of treatment, inter-examination time intervals, etc...</span></li><li class="c10 c20"><span class="c6">Permutation</span><span>&nbsp;<br>Scramble values of attributes among individuals. This preserves statistical characteristics within each variable on its own, but it no longer becomes possible to study correlations between variables.</span></li></ol><p class="c7"><span>A similar guide aimed at the general public has been produced by the UK information commissioner&#39;s office: </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://ico.org.uk/media/1061/anonymisation-code.pdf&amp;sa=D&amp;ust=1576784592060000">ICO anonymization code of practice</a></span><span>.</span><span>&nbsp;</span><span>Implications for UK administrative data research have also been </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.sciencedirect.com/science/article/pii/S0267364918300153&amp;sa=D&amp;ust=1576784592060000">published</a></span><span>.</span></p><p class="c3"><span class="c0"></span></p><p class="c20"><span class="c0">Examples: Can I extract data from a random subset of individuals rather than the complete population? Can I pseudonymize after linking data from different sources? Can I delete the identifying raw data? Can I adequately protect any encryption keys used for the raw data? Can I delete them? </span></p><h3 class="c17" id="h.2zdx4co9xlpx"><span>Organizational protective measures</span></h3><p class="c7"><span class="c0">This entails demonstrating limiting access to only the authorized people, limiting the number of authorized people, having suitable information security policies, ensuring appropriate competencies and compliance, having necessary agreements in place, not using third party services that cannot give sufficient legal and technical guarantees for safeguarding the data, etc.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Examples: Can the pseudonymization key be kept in a safe, only accessible to senior project management? Can we implement project separation, so that researchers who are engaged in several projects cannot mix data from different projects by mistake? Can we use only systems operated by public authorities such as a university, which are bound by public access to information and secrecy law (OSL)? Do we have access to any systems that have already been deemed secure enough for this processing? If we must use a cloud provider or other third party for processing, can we choose a national one? Who procured it and deemed it safe for use with this kind of data, and on what basis? Does the data processing agreement cover all necessary processing? Can we guarantee that all who access data has affirmed their identity at some point, for example by showing their passport at employment or account generation? Are they required by law or legally binding contract to not disclose data (&quot;tystnadsplikt&quot;)?</span></p><h3 class="c17" id="h.vhhin4v1sk1u"><span>Technical protective measures</span></h3><p class="c7"><span class="c0">To be effective, modern research makes frequent and powerful use of staggeringly complex technical systems (such as computers and networks) which can be made to function in weird and wondrous ways. The set of technical protective measures possible to employ is therefore similarly diverse and complex, as this concerns security in depth at many abstraction levels, and where the devil truly is in the details. Most of these measures concern limiting attack surfaces to what is necessary and possible to follow up. Commonly employed tools are encryption and access control.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Examples: </span></p><ul class="c14 lst-kix_4gne5gp2bb3o-0 start"><li class="c7 c10"><span class="c6">Transmissions</span><span class="c0">&nbsp;Can we encrypt our transmissions to protect against eavesdropping? Is it more safe to send the data over a secured network connection than sending it by mail?</span></li><li class="c7 c10"><span class="c6">Authentication and authorization</span><span>&nbsp;Can we send access credentials over separate connections to protect against impersonation? Can we use multi-factor authentication (username, password, project name, client certificates, verification codes by sms or </span><span>TOTP, separate VPN login,</span><span class="c0">&nbsp;etc...)? Can we use one-time or time dependent passwords to protect against replay attacks? Can we keep access logs and monitor them for irregularities? </span></li><li class="c7 c10"><span class="c6">Networking</span><span class="c0">&nbsp;Can we restrict the IP ranges that can access the systems? Can we limit the attack surface by limiting the number of services on open network ports? Can we close down everything, and then open only what we explicitly need? Can we limit Internet access to protect against malicious code? Can we disallow outgoing connections altogether? (And then open only what we explicitly need, eg for security updates)?</span></li><li class="c7 c10"><span class="c6">Systems</span><span class="c0">&nbsp;Can we reduce the attack surface by limiting the number of softwares and systems and modes of use? Can we ensure all software is from trusted sources and continuously security patched? </span></li><li class="c7 c10"><span class="c6">Storage</span><span class="c0">&nbsp;Can we encrypt data at rest to protect against theft? Can we use encrypted disks such that they cannot be read if removed from the computer? Can we use disk retention clauses (eg document and destroy broken hardware on premise rather than returning it) to reduce the risk of unlawful data recovery off-premise? </span></li><li class="c7 c10"><span class="c6">Encryption</span><span>&nbsp;Can I ensure only strong-enough encryption is used for this data? How can I demonstrate that encryption keys are adequately protected.</span></li></ul><h2 class="c13" id="h.5eqhfrq5f4m2"><span class="c18">Ethics and protective measures in research on clinical data </span></h2><p class="c7"><span class="c0">As noted in the preceding section, it is a good practice to choose protective measures such that they do not hinder research activities that foreseeably could add significant value to individuals and society. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Taking data sharing in medical imaging research as an example: extraction of clinical imaging data for research requires significant effort from caregivers that could be otherwise be spent treating the sick, so there exists a solid ethical argument that once extracted we have a moral obligation to use the data as well as we can, as extensively as possible, and in as many research projects as possible, in order to give the best possible value to individuals and society in the present and future for the effort invested. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Such a stance of course requires that researchers take every care to employ excellent and appropriate protective measures to reduce any resulting risk to individuals and society. This balancing of risk against public interest and protective measures put in place is what is evaluated in an ethical review application to the Swedish ethical review authority (&quot;etikpr&ouml;vningsmyndigheten&quot;, EPM). If the researcher successfully defends their choices, the application is approved and provides a framework for what research activities are legally and ethically allowed.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">There is however a danger of needlessly limiting the research activities by overspecifying them in the ethical review application.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>Taking statistical processing as an example: the exact equations used are perhaps less important than the fact that &quot;advanced statistical methods&quot; will be used, and neither of these perhaps constitute risks that need to be defended with special protective measures in an ethical review application. Rather, it may be more pertinent to state that the exact choice of statistical method is preliminary, and then go on to describe what systems will be used to process the data and who will have access to them, how the data will be sent there, how long it will be kept, and how results will be extracted. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>If it turns out that potentially valuable research activities (such as</span><span>&nbsp;data sharing</span><span class="c0">&nbsp;to enable further research) are not explicitly covered by language in the approved ethical review application, the researcher can seek support for these activities by motivating them in a change application to the EPM, which normally takes less time and effort than a full review. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The key lesson is to identify what are risks, and what are not risks, choose protective measures to counteract the risks, specify them, and motivate the choices. Another important take-home message is that it can sometimes be more ethical to aim </span><span>higher</span><span class="c0">. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://docs.google.com/document/d/1TvjTeoUiqaafnBQGaJDjHcFCUBfhiKmUTWJG_bkGIWs/edit%23heading%3Dh.i639kmr8va6o&amp;sa=D&amp;ust=1576784592070000">AIDA definition of anonymous data</a></span><span>&nbsp;is described in AIDA GDPR policy 1.0. </span><span class="c9"><a class="c2" href="#h.y634q6va22h">Appendix 3</a></span><span>&nbsp;describes what AIDA considers correct anonymization in medical imaging using examples from the </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://datasets.aida.medtech4health.se/&amp;sa=D&amp;ust=1576784592071000">AIDA dataset register</a></span><span class="c0">&nbsp;along with rationale to support researchers trying to choose appropriate anonymization methods for their own datasets.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c9"><a class="c2" href="#h.jq11ducoq2g1">Appendix 2</a></span><span class="c0">&nbsp;holds examples of language in ethical review applications to support data sharing in research.</span></p><hr style="page-break-before:always;display:none;"><h1 class="c8" id="h.wbomzglh2rsl"><span class="c27"></span></h1><h1 class="c19" id="h.g2on669tl3wd"><span class="c27">AIDA data sharing</span></h1><p class="c7"><span>AIDA policies are set continuously by </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida/organisation/&amp;sa=D&amp;ust=1576784592072000">AIDA management</a></span><span class="c0">, who reports to the AIDA steering group.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">AIDA supports data sharing in the following ways:</span></p><ol class="c14 lst-kix_dfpsym14kryb-0 start" start="1"><li class="c7 c10"><span class="c9"><a class="c2" href="#h.hlxrehmxegqn">AIDA data hub sharing</a></span><span class="c0">, which is the primary mode of data sharing in AIDA.</span></li><li class="c7 c10"><span class="c9"><a class="c2" href="#h.9apftz6x3kl3">Large-scale data exports</a></span><span class="c0">&nbsp;from clinical production systems.</span></li><li class="c7 c10"><span class="c9"><a class="c2" href="#h.3bhcfaugzh1a">Selective sharing</a></span><span class="c0">&nbsp;only with specified research groups. </span></li><li class="c7 c10"><span class="c9"><a class="c2" href="#h.twa5knd31zt8">Support to ethical review applications</a></span><span class="c0">&nbsp;that include data sharing aspects.</span></li><li class="c7 c10"><span class="c9"><a class="c2" href="#h.451bq2n1myw">Facilitating data sharing outside of AIDA</a></span><span class="c0">.</span></li></ol><p class="c3"><span class="c0"></span></p><p class="c7"><span>The primary tool for data sharing in AIDA is the </span><span class="c9"><a class="c2" href="#h.6l9xvf91th8p">AIDA PACS</a></span><span>, however AIDA also supports self-service </span><span class="c9"><a class="c2" href="#h.wy3qtdodds44">file sharing</a></span><span class="c0">&nbsp;among AIDA members.</span></p><hr style="page-break-before:always;display:none;"><p class="c3"><span class="c0"></span></p><h2 class="c13" id="h.narguwpbdajr"><span>Overview</span></h2><p class="c7"><span>This section describes the process from research idea all the way to sharing research data with the greater research community for better impact and visibility, and </span><span>highlights</span><span>&nbsp;the steps where AIDA can help. AIDA can offer some support to non-members in steps 2-5 below </span><span class="c44">(blue)</span><span>, but membership is required for major support and from step 6 on </span><span class="c46">(green)</span><span class="c0">.</span></p><p class="c3"><span class="c0"></span></p><ol class="c14 lst-kix_l1zr2qb3o8je-0 start" start="1"><li class="c40"><span class="c6">Become part of AIDA</span><span class="c1">&nbsp;</span><span class="c6"><br></span><span class="c9"><a class="c2" href="#h.scwhib8fehup">Several ways exist</a></span><span class="c0">. Sharing prioritized data on the data hub is one way. </span></li><li class="c30"><span class="c6">Ethical review application</span><span class="c1">&nbsp;</span><span><br>Apply to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://etikprovningsmyndigheten.se/&amp;sa=D&amp;ust=1576784592078000">EPM</a></span><span>&nbsp;for ethical review. Include </span><span class="c9"><a class="c2" href="#h.5eqhfrq5f4m2">data sharing aspects</a></span><span>. AIDA can </span><span class="c9"><a class="c2" href="#h.jq11ducoq2g1">help you</a></span><span class="c0">. </span></li><li class="c30"><span class="c6">Prioritized data?</span><span><br>AIDA can cover costs for data hub sharing of </span><span class="c9"><a class="c2" href="#h.whe481t5b3jz">prioritized data</a></span><span class="c0">.</span></li><li class="c30"><span class="c6">Get research data</span><span><br>Use your ethical approval to get data from caregivers and other data sources. Before disclosing data, these will assess if disclosure will lead to harm (&quot;menpr&ouml;vning&quot;). </span><span class="c9"><a class="c2" href="#h.yj4ewpf0zyau">Pseudonymize and protect your data</a></span><span>. AIDA offers </span><span class="c9"><a class="c2" href="#h.w5xq3lct75vd">support, tools</a></span><span>&nbsp;and </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://datasets.aida.medtech4health.se/&amp;sa=D&amp;ust=1576784592080000">data</a></span><span class="c0">.</span></li><li class="c33"><span class="c6">Anonymize data?</span><span><br>Presently, AIDA only accepts </span><span class="c9"><a class="c2" href="#h.7h4e0ukokja3">anonymous data</a></span><span>. AIDA offers </span><span class="c9"><a class="c2" href="#h.y634q6va22h">examples</a></span><span>, </span><span class="c9"><a class="c2" href="#h.w5xq3lct75vd">support and tools</a></span><span class="c0">. </span></li><li class="c31"><span class="c6">Upload data</span><span class="c1">&nbsp;</span><span><br>Contact an </span><span class="c9"><a class="c2" href="mailto:aida-data-director@medtech4health.se">AIDA system administrator</a></span><span>&nbsp;to upload data to the AIDA platform. You can use the </span><span class="c9"><a class="c2" href="#h.6l9xvf91th8p">AIDA PACS</a></span><span class="c0">&nbsp;to visually inspect your data. Only you can see your data. </span></li><li class="c31"><span class="c6">Share in AIDA</span><span><br>AIDA members you share with can see your data. An </span><span class="c9"><a class="c2" href="mailto:aida-data-director@medtech4health.se">AIDA system administrator</a></span><span class="c0">&nbsp;can make a working copy for download or more advanced analyses. You will be notified, or asked to approve if you have explicitly requested this.</span></li><li class="c31"><span class="c6">Data hub sharing?</span><span><br>AIDA encourages </span><span class="c9"><a class="c2" href="#h.hlxrehmxegqn">data hub sharing</a></span><span>. AIDA </span><span class="c9"><a class="c2" href="#h.h3cq089iumt4">advertises shared datasets</a></span><span>, and makes them </span><span class="c9"><a class="c2" href="#h.6oox52vnqj5l">citable in research</a></span><span class="c0">&nbsp;using DOIs.</span></li><li class="c31"><span class="c6">Full or sample data hub sharing?</span><span><br>In the interest of OpenScience, you should make full data available </span><span class="c9"><a class="c2" href="#h.j4fejy63shai">on request</a></span><span class="c0">.</span></li><li class="c31"><span class="c6">Select data hub sharing license</span><span><br>AIDA promotes the </span><span class="c9"><a class="c2" href="#h.ndofpje4mr7r">AIDA BY license</a></span><span class="c0">&nbsp;which allows use within AIDA.</span></li><li class="c38"><span class="c6">Share outside of AIDA</span><span><br>AIDA will notify you of access requests, and can </span><span class="c9"><a class="c2" href="#h.451bq2n1myw">facilitate contacts</a></span><span>&nbsp;with requesters for data sharing options outside of AIDA, and can facilitate transfers to recipients outside AIDA based on your instructions.</span></li></ol><h2 class="c13" id="h.scwhib8fehup"><span class="c18">Getting access</span></h2><p class="c7"><span>AIDA shares data primarily within AIDA (cf </span><span class="c9"><a class="c2" href="#h.7h4e0ukokja3">Personal data and legal basis</a></span><span>&nbsp;below</span><span>), however researchers outside of AIDA can become part of AIDA, for example by engaging in an AIDA funded activity such as a </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida-en/innovation-projects/&amp;sa=D&amp;ust=1576784592086000">project</a></span><span>, </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida-en/fellowships/&amp;sa=D&amp;ust=1576784592087000">fellowship</a></span><span>&nbsp;or </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida-en/apply-for-clinical-evaluation/&amp;sa=D&amp;ust=1576784592087000">clinical evaluation</a></span><span>, or by becoming </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida-en/network-partner/&amp;sa=D&amp;ust=1576784592088000">network partner</a></span><span>. The membership fee for network partners is low, but some fee is important as a means to establish that a meaningful commitment has been made. It can be waived if the network partner contributes by other means, for example by </span><span class="c9"><a class="c2" href="#h.hlxrehmxegqn">sharing prioritized data</a></span><span class="c0">. </span></p><h2 class="c13" id="h.7h4e0ukokja3"><span class="c18">Personal data and legal basis</span></h2><p class="c7"><span>AIDA engages in research and innovation using data mainly from medical imaging, and thus has an obligation under the general data protection regulation (GDPR) to adequately safeguard the privacy of the individuals concerned. For this reason -and to protect against for example mistakes in large scale anonymization- AIDA engages in data sharing for research only when it is ethically approved, and when a contractual agreement is in place that includes non-disclosure of data, such as AIDA partner contracts. More details including the </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://docs.google.com/document/d/1TvjTeoUiqaafnBQGaJDjHcFCUBfhiKmUTWJG_bkGIWs/edit%23heading%3Dh.i639kmr8va6o&amp;sa=D&amp;ust=1576784592089000">AIDA definition of anonymous data</a></span><span>&nbsp;can be found in the </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://docs.google.com/document/d/1TvjTeoUiqaafnBQGaJDjHcFCUBfhiKmUTWJG_bkGIWs/edit&amp;sa=D&amp;ust=1576784592090000">AIDA GDPR policy 1.0</a></span><span class="c0">. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">AIDA can presently only host anonymous data due to terms in the data processing agreement for the present AIDA platform. At the time of writing AIDA is reworking its platform to be sufficiently secure also for sensitive personal data, at which point AIDA will be able to support further modes of data sharing.</span></p><h2 class="c13" id="h.wgbk2wn4v2tr"><span>Roles</span></h2><p class="c7"><span class="c0">AIDA uses the following roles in relation to sharing datasets:</span></p><p class="c3"><span class="c0"></span></p><ul class="c14 lst-kix_1qb3ubekxfb5-0 start"><li class="c7 c10"><span class="c6">Author:</span><span class="c0">&nbsp;The list of persons who are credited with the work in producing the dataset, be it in defining the selection criteria, or gathering, structuring, enriching, or annotating the data, or for leading or funding the work. This is comparable to the list of authors in an academic publication.</span></li><li class="c7 c10"><span class="c6">Copyright holder</span><span class="c0">: The legal entity holding the copyright (&quot;upphovsr&auml;tt&quot;) to the dataset. This is normally given by the approved ethical review application (&quot;godk&auml;nd etikpr&ouml;vingsans&ouml;kan&quot;) for the research project, as the research institution (&quot;forskningshuvudman&quot;) represented by a named competent researcher (&quot;ansvarig forskare&quot;) under whose supervision the research activities -such as this data sharing- are taking place.</span></li><li class="c7 c10"><span class="c6">Contact</span><span class="c0">: Contact points for information on the dataset and for access requests. This can be any person, but usually it is a good idea to include at least the first author, the copyright holder, and some contact person from AIDA for redundancy such as the data director. </span></li></ul><h2 class="c13" id="h.mghk8xc1gise"><span class="c18">Tools</span></h2><h3 class="c17" id="h.6l9xvf91th8p"><span class="c11">AIDA PACS</span></h3><p class="c7"><span class="c0">The AIDA Picture Archive and Communication System (PACS) is available here:</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://aida.medtech4health.se/ids7/&amp;sa=D&amp;ust=1576784592094000">https://aida.medtech4health.se/ids7/</a></span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The AIDA PACS is the primary tool for data storage, visualization, interaction and sharing in AIDA. AIDA members can contact an </span><span class="c9"><a class="c2" href="mailto:aida-data-director@medtech4health.se">AIDA system administrator</a></span><span class="c0">&nbsp;to upload data, or download data for more advanced analyses.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">AIDA has chosen a PACS as its main tool for interacting with data, since a PACS is what medical imaging diagnostics professionals use as their main tool for their everyday work in the clinic, and is therefore what imaging diagnostics AI products must integrate well with in order to feasibly add value to clinical practice. Using a PACS in this way ensures that clinicians can easily remain involved throughout any AIDA supported development activity, so that requirements can be actively driven by clinical perspective, from research idea, through implementation in a CE-marked medical device, to clinical evaluation and procurement for use in diagnosis of patients. We believe that engaging across the full value chain and connecting it in every step to as unfalsifiable needs and consequences as possible, will contribute to more relevant research and innovation, and higher impact from more reproducible science, as well as better outcomes for patients.</span></p><h3 class="c17" id="h.wy3qtdodds44"><span class="c11">File sharing</span></h3><p class="c7"><span class="c0">The AIDA OwnCloud service for self-service file sharing is available here:</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://owncloud.aida.medtech4health.se/&amp;sa=D&amp;ust=1576784592097000">https://owncloud.aida.medtech4health.se/</a></span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">AIDA members can use the AIDA OwnCloud file sharing service to store and share data with other AIDA members. OwnCloud is quite intuitive to use, so AIDA members can use it for straightforward basic sharing without system administrator assistance. </span></p><h3 class="c17" id="h.w5xq3lct75vd"><span>Tools for l</span><span>arge-scale data exports</span></h3><p class="c7"><span>AIDA supports and can share tools for large-scale data exports from clinical production systems in medical imaging. Please see </span><span class="c9"><a class="c2" href="#h.9apftz6x3kl3">large-scale data exports</a></span><span class="c0">&nbsp;below.</span></p><h2 class="c13" id="h.hlxrehmxegqn"><span class="c18">AIDA data hub sharing</span></h2><p class="c7"><span>The AIDA data hub is the primary means of data sharing in AIDA. It is used for legal and ethically approved research data sharing (cf </span><span class="c9"><a class="c2" href="#h.7h4e0ukokja3">Personal data and legal basis</a></span><span class="c0">&nbsp;above). AIDA covers costs for sharing prioritized data on the AIDA data hub. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>A typical scenario for AIDA data hub sharing is that a research institution as copyright holder for the prioritized research data contacts an </span><span class="c9"><a class="c2" href="mailto:aida-data-director@medtech4health.se">AIDA system administrator</a></span><span>&nbsp;to</span><span class="c0">&nbsp;share the data on the data hub for use within AIDA under specific licensing terms. Thereby, the data is seen as a resource that is accessible to AIDA partners for use within AIDA. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>This is in line with what we perceive as </span><span class="c9"><a class="c2" href="#h.gi4cgl6sjilc">common practice in the use of clinical imaging data for research in Sweden</a></span><span>&nbsp;(cf </span><span>above</span><span>). The ethical and legal context around this common practice is discussed in </span><span class="c9"><a class="c2" href="#h.6t1pdq248vyk">Appendix 1</a></span><span class="c0">. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Please see the following sections for details:</span></p><ol class="c14 lst-kix_l0hhxagkhkxi-0 start" start="1"><li class="c7 c10"><span class="c9"><a class="c2" href="#h.h3cq089iumt4">AIDA dataset register</a></span><span class="c0">&nbsp;- Citability and public exposure for shared datasets.</span></li><li class="c7 c10"><span class="c9"><a class="c2" href="#h.j4fejy63shai">Modes of access</a></span></li><li class="c7 c10"><span class="c9"><a class="c2" href="#h.whe481t5b3jz">Scope and priorities</a></span></li><li class="c7 c10"><span class="c9"><a class="c2" href="#h.sdomrkpb15ym">AIDA data sharing licenses</a></span><span>&nbsp;- Commonly used terms for sharing.</span></li></ol><h3 class="c17" id="h.h3cq089iumt4"><span class="c11">AIDA dataset register</span></h3><p class="c7"><span class="c0">The AIDA dataset register shows public information on the datasets that have been shared on the AIDA data hub, and is available here:</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://datasets.aida.medtech4health.se/&amp;sa=D&amp;ust=1576784592103000">https://datasets.aida.medtech4health.se/</a></span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The AIDA dataset register is used to advertise shared datasets, and to make shared datasets citable in academic research papers using Digital Object Identifiers (DOI). See </span><span class="c9"><a class="c2" href="#h.6oox52vnqj5l">Visibility, citability, and digital object identifiers</a></span><span>&nbsp;below for more details</span><span>. </span></p><h3 class="c17" id="h.j4fejy63shai"><span>Modes of a</span><span class="c11">ccess</span></h3><p class="c7"><span>AIDA members can visually inspect and interact with the data that they have access to through the </span><span class="c9"><a class="c2" href="#h.6l9xvf91th8p">AIDA PACS</a></span><span>. For use in more advanced analyses within the dataset&#39;s sharing license, a working copy can be obtained on request to an </span><span class="c9"><a class="c2" href="mailto:aida-data-director@medtech4health.se">AIDA system administrator</a></span><span class="c0">. Copyright holders will be notified of the use, but will be asked to approve the use if they have expressly requested this. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>Data shared on the AIDA data hub is by default available either in full or in part on the </span><span class="c9"><a class="c2" href="#h.6l9xvf91th8p">AIDA PACS</a></span><span>, and shall in the interest of OpenScience be made available in full on request to the copyright holder. </span></p><h3 class="c17" id="h.whe481t5b3jz"><span class="c11">Scope and priorities</span></h3><p class="c7"><span>AIDA </span><span>can cover </span><span class="c0">costs for sharing, extraction and enrichment of prioritized data on the AIDA data hub. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://datasets.aida.medtech4health.se/prio&amp;sa=D&amp;ust=1576784592107000">AIDA data priorities</a></span><span>&nbsp;are continuously set by the </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida/organisation/&amp;sa=D&amp;ust=1576784592107000">AIDA data hub clinical council</a></span><span>, to enable development of those AI tools that will best meet the needs of current and future clinical practice. The data priorities are being continuously updated based on current data hub composition and identified clinical needs. Please </span><span class="c9"><a class="c2" href="mailto:aida-data-director@medtech4health.se">contact the AIDA data director</a></span><span class="c0">&nbsp;for proposals for data extraction or to suggest further data acquisition topics.</span></p><h3 class="c17" id="h.6oox52vnqj5l"><span class="c11">Visibility, citability, and digital object identifiers</span></h3><p class="c7"><span>The </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://datasets.aida.medtech4health.se/&amp;sa=D&amp;ust=1576784592109000">AIDA dataset register</a></span><span>&nbsp;is used to advertise and provide information on datasets that have been shared on the data hub, and to make them citable in academic research papers using Digital Object Identifiers (</span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.doi.org/&amp;sa=D&amp;ust=1576784592109000">DOI</a></span><span>). This helps promote OpenScience, and helps make shared datasets more Findable, Accessible, Interoperable and Reusable (</span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.go-fair.org/&amp;sa=D&amp;ust=1576784592110000">FAIR</a></span><span class="c0">)</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">AIDA acknowledges that data collection and preparation is an important part of any data science endeavor, and that recognizing it as such will stimulate further sharing, which will lead to more impactful research and improved patient benefit.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>DOIs work by means of the global</span><span><a class="c2" href="https://www.google.com/url?q=https://doi.org/&amp;sa=D&amp;ust=1576784592111000">&nbsp;</a></span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://doi.org/&amp;sa=D&amp;ust=1576784592111000">DOI system</a></span><span class="c0">, such that following a DOI link for a dataset will always take you its official landing page, which holds the latest updated information on that dataset. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>Example: 10.23698/aida/ctpa &rarr;</span><span><a class="c2" href="https://www.google.com/url?q=https://doi.org/10.23698/aida/ctpa&amp;sa=D&amp;ust=1576784592112000">&nbsp;</a></span><span class="c9 c43"><a class="c2" href="https://www.google.com/url?q=https://doi.org/10.23698/aida/ctpa&amp;sa=D&amp;ust=1576784592112000">https://doi.org/10.23698/aida/ctpa</a></span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>AIDA has its own</span><span><a class="c2" href="https://www.google.com/url?q=https://search.datacite.org/works?query%3Dsnd.aida&amp;sa=D&amp;ust=1576784592112000">&nbsp;</a></span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://search.datacite.org/works?query%3Dsnd.aida&amp;sa=D&amp;ust=1576784592113000">DOI prefix</a></span><span>&nbsp;provided by</span><span><a class="c2" href="https://www.google.com/url?q=https://datacite.org&amp;sa=D&amp;ust=1576784592113000">&nbsp;</a></span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://datacite.org&amp;sa=D&amp;ust=1576784592113000">DataCite</a></span><span>&nbsp;through the </span><span>Swedish National Data Service (</span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://snd.gu.se/en&amp;sa=D&amp;ust=1576784592114000">SND</a></span><span>), and has made the data hub and its datasets discoverable through the global</span><span><a class="c2" href="https://www.google.com/url?q=https://www.re3data.org&amp;sa=D&amp;ust=1576784592114000">&nbsp;</a></span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.re3data.org&amp;sa=D&amp;ust=1576784592114000">re3data.org</a></span><span>&nbsp;registry of research data repositories, here: </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.re3data.org/repository/r3d100013031&amp;sa=D&amp;ust=1576784592115000">AIDA data hub on re3data</a></span><span class="c0">. </span></p><h3 class="c17" id="h.sdomrkpb15ym"><span>AIDA data sharing </span><span>licenses</span></h3><p class="c7"><span class="c0">For data hub sharing AIDA recommends using one of the license types that are enumerated in decreasing preference here and further described below:</span></p><ol class="c14 lst-kix_z9mazreum7w0-0 start" start="1"><li class="c7 c10"><span class="c0">AIDA BY license.</span></li><li class="c7 c10"><span class="c0">AIDA license.</span></li><li class="c7 c10"><span class="c0">AIDA CA / AIDA BY CA license (for limited time and until first publication).</span></li></ol><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">If the terms of these licenses are not suitable for a specific case of sharing, then the copyright holder is welcome to contact AIDA to agree on more suitable terms for sharing. </span></p><h4 class="c25" id="h.hqqqco4ysz3j"><span class="c26">AIDA license</span></h4><p class="c7"><span>The AIDA license is adapted from the succinct, understandable and permissive </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://opensource.org/licenses/ISC&amp;sa=D&amp;ust=1576784592117000">ISC license</a></span><span>&nbsp;</span><span class="c0">commonly used in open source software, but modified here to disallow use outside of AIDA. This restriction is a safeguard against mistakes, for example in large scale anonymization, which may otherwise lead to privacy breach. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Example:</span></p><p class="c3"><span class="c0"></span></p><p class="c21"><span class="c0">Copyright &lt;Year&gt; &lt;Copyright holder&gt;</span></p><p class="c21 c28"><span class="c0"></span></p><p class="c21"><span>Permission to use, copy, modify, and/or distribute this data within AIDA (Analytic Imaging Diagnostics Arena </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida&amp;sa=D&amp;ust=1576784592119000">https://medtech4health.se/aida</a></span><span class="c0">) for any purpose with or without fee is hereby granted, provided that the above copyright notice and this permission notice appear in all copies.</span></p><p class="c21 c28"><span class="c0"></span></p><p class="c21"><span class="c0">THE DATA IS PROVIDED &quot;AS IS&quot; AND THE AUTHOR DISCLAIMS ALL WARRANTIES WITH REGARD TO THIS DATA INCLUDING ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS. IN NO EVENT SHALL THE AUTHOR BE LIABLE FOR ANY SPECIAL, DIRECT, INDIRECT, OR CONSEQUENTIAL DAMAGES OR ANY DAMAGES WHATSOEVER RESULTING FROM LOSS OF USE, DATA OR PROFITS, WHETHER IN AN ACTION OF CONTRACT, NEGLIGENCE OR OTHER TORTIOUS ACTION, ARISING OUT OF OR IN CONNECTION WITH THE USE OR CHARACTERISTICS OF THIS DATA.</span></p><h4 class="c25" id="h.ndofpje4mr7r"><span class="c26">AIDA BY license</span></h4><p class="c7"><span>AIDA recommends the AIDA BY license for most cases of data hub sharing, for reasons described in the section on </span><span class="c9"><a class="c2" href="#h.6oox52vnqj5l">Visibility, citability, and digital object identifiers</a></span><span>&nbsp;above</span><span class="c0">. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The AIDA BY license type builds on the AIDA license (cf </span><span class="c9"><a class="c2" href="#h.hqqqco4ysz3j">above</a></span><span class="c0">) and adds attribution requirements on publications resulting from the use of the data, for example by citing the dataset and related papers and/or including an acknowledgement text.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Example:</span></p><p class="c3"><span class="c0"></span></p><p class="c21"><span class="c0">Copyright &lt;Year&gt; &lt;Copyright holder&gt;</span></p><p class="c21 c28"><span class="c0"></span></p><p class="c21"><span>Permission to use, copy, modify, and/or distribute this data within AIDA (Analytic Imaging Diagnostics Arena </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida&amp;sa=D&amp;ust=1576784592122000">https://medtech4health.se/aida</a></span><span class="c0">) for any purpose with or without fee is hereby granted, provided that the above copyright notice and this permission notice appear in all copies, and that publications resulting from the use of this data &lt;OPTIONAL: include the following acknowledgement text &ldquo;...&rdquo; and&gt; cite the following publications:</span></p><p class="c21 c28"><span class="c0"></span></p><p class="c21"><span class="c0">&lt;This dataset&gt;</span></p><p class="c21"><span class="c0">&lt;Paper 1&gt;</span></p><p class="c21"><span class="c0">&lt;Paper 2&gt;</span></p><p class="c21 c28"><span class="c0"></span></p><p class="c21"><span class="c0">THE DATA IS PROVIDED &quot;AS IS&quot; AND THE AUTHOR DISCLAIMS ALL WARRANTIES WITH REGARD TO THIS DATA INCLUDING ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS. IN NO EVENT SHALL THE AUTHOR BE LIABLE FOR ANY SPECIAL, DIRECT, INDIRECT, OR CONSEQUENTIAL DAMAGES OR ANY DAMAGES WHATSOEVER RESULTING FROM LOSS OF USE, DATA OR PROFITS, WHETHER IN AN ACTION OF CONTRACT, NEGLIGENCE OR OTHER TORTIOUS ACTION, ARISING OUT OF OR IN CONNECTION WITH THE USE OR CHARACTERISTICS OF THIS DATA.</span></p><p class="c3"><span class="c0"></span></p><h4 class="c25" id="h.4jzyr84k3cg7"><span class="c26">AIDA CA license </span></h4><p class="c7"><span class="c6">Note: </span><span class="c0">Only recommended by AIDA for limited time and until first publication.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The AIDA CA license type builds on the AIDA license (cf </span><span class="c9"><a class="c2" href="#h.hqqqco4ysz3j">above</a></span><span class="c0">) and adds a requirement that publications resulting from the use of this data include (specified) dataset authors in the author list. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">AIDA only promotes using this license for limited time and for datasets where data collection is actively ongoing, such that the dataset authors can be seen to make a clear contribution to the publication. The intended effect is to increase and reward early sharing, and to stimulate forming new research collaborations, which may influence aspects of data collection toward greater generalizability to support further lines of research inquiry. Once an AIDA CA licensed dataset has been used in a publication, AIDA recommends changing the license to no longer require co-authorship, but rather citations or similar, in line with good OpenScience research tradition and ethics.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Example:</span></p><p class="c3"><span class="c0"></span></p><p class="c21"><span class="c0">Copyright &lt;Year&gt; &lt;Copyright holder&gt;</span></p><p class="c21 c28"><span class="c0"></span></p><p class="c21"><span>Permission to use, copy, modify, and/or distribute this data within AIDA (Analytic Imaging Diagnostics Arena </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida&amp;sa=D&amp;ust=1576784592127000">https://medtech4health.se/aida</a></span><span class="c0">) for any purpose with or without fee is hereby granted, provided that the above copyright notice and this permission notice appear in all copies, and that publications resulting from the use of this data include the authors of this dataset &lt;optional: NN, NN, and NN&gt; in the author list.</span></p><p class="c21 c28"><span class="c0"></span></p><p class="c21"><span class="c0">THE DATA IS PROVIDED &quot;AS IS&quot; AND THE AUTHOR DISCLAIMS ALL WARRANTIES WITH REGARD TO THIS DATA INCLUDING ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS. IN NO EVENT SHALL THE AUTHOR BE LIABLE FOR ANY SPECIAL, DIRECT, INDIRECT, OR CONSEQUENTIAL DAMAGES OR ANY DAMAGES WHATSOEVER RESULTING FROM LOSS OF USE, DATA OR PROFITS, WHETHER IN AN ACTION OF CONTRACT, NEGLIGENCE OR OTHER TORTIOUS ACTION, ARISING OUT OF OR IN CONNECTION WITH THE USE OR CHARACTERISTICS OF THIS DATA.</span></p><p class="c3"><span class="c0"></span></p><h4 class="c25" id="h.bfbi57byl90q"><span class="c26">AIDA BY CA license</span></h4><p class="c7"><span class="c6">Note:</span><span class="c0">&nbsp;Only recommended for limited time and until first publication.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">The AIDA BY CA license type is a combination of the AIDA BY and AIDA CA licensing terms.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Example:</span></p><p class="c3"><span class="c0"></span></p><p class="c21"><span class="c0">Copyright &lt;Year&gt; &lt;Copyright holder&gt;</span></p><p class="c21 c28"><span class="c0"></span></p><p class="c21"><span>Permission to use, copy, modify, and/or distribute this data within AIDA (Analytic Imaging Diagnostics Arena </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://medtech4health.se/aida&amp;sa=D&amp;ust=1576784592129000">https://medtech4health.se/aida</a></span><span class="c0">) for any purpose with or without fee is hereby granted, provided that the above copyright notice and this permission notice appear in all copies, and that publications resulting from the use of this data include the authors of this dataset &lt;optional: NN, NN, and NN&gt; in the author list and &lt;optional: include the following acknowledgement text &ldquo;...&rdquo; and&gt; &lt;optional: cite the following publications:</span></p><p class="c21 c28"><span class="c0"></span></p><p class="c21"><span class="c0">&lt;This dataset&gt;</span></p><p class="c21"><span class="c0">&lt;Paper 1&gt;</span></p><p class="c21"><span class="c0">&lt;Paper 2&gt;</span></p><p class="c21 c28"><span class="c0"></span></p><p class="c21"><span class="c0">THE DATA IS PROVIDED &quot;AS IS&quot; AND THE AUTHOR DISCLAIMS ALL WARRANTIES WITH REGARD TO THIS DATA INCLUDING ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS. IN NO EVENT SHALL THE AUTHOR BE LIABLE FOR ANY SPECIAL, DIRECT, INDIRECT, OR CONSEQUENTIAL DAMAGES OR ANY DAMAGES WHATSOEVER RESULTING FROM LOSS OF USE, DATA OR PROFITS, WHETHER IN AN ACTION OF CONTRACT, NEGLIGENCE OR OTHER TORTIOUS ACTION, ARISING OUT OF OR IN CONNECTION WITH THE USE OR CHARACTERISTICS OF THIS DATA.</span></p><h2 class="c13" id="h.9apftz6x3kl3"><span>Large-scale data exports</span></h2><p class="c7"><span>AIDA can support large-scale exports of medical imaging data for research. Researchers and caregivers are welcome to </span><span class="c9"><a class="c2" href="mailto:aida-data-director@medtech4health.se">contact AIDA</a></span><span>&nbsp;with any questions relating to this matter.</span><span class="c0">&nbsp;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Such exports are often problematic for caregivers and research institutions for practical reasons since data may be large, possibly sensitive, and hard to transfer without affecting the performance of networks and equipment that may be critical for patient well-being.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Engaging with AIDA for large scale exports can be a way for caregivers to ensure that a well understood regulatory compliant procedure is used, and that critical operations will not be disrupted. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The recommended process is to transfer the data for </span><span class="c9"><a class="c2" href="#h.hlxrehmxegqn">AIDA data hub sharing</a></span><span>&nbsp;if possible</span><span class="c0">, to enable more research groups to ethically and legally utilize the data in further research, thereby generating more value for research and the clinic for the same effort spent in data extraction.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>AIDA can also support exports for </span><span class="c9"><a class="c2" href="#h.3bhcfaugzh1a">selective sharing</a></span><span class="c0">&nbsp;if data hub sharing is not possible. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">AIDA also offers advice and shares tools to support exports to other destinations.</span></p><h2 class="c13" id="h.3bhcfaugzh1a"><span>Selective sharing</span></h2><p class="c7"><span>AIDA members can upload private data to the AIDA platform, and can choose to share data selectively with other specified research groups in AIDA at own cost. This can be done either through the </span><span class="c9"><a class="c2" href="#h.6l9xvf91th8p">AIDA PACS</a></span><span>&nbsp;by request to an </span><span class="c9"><a class="c2" href="mailto:aida-data-director@medtech4health.se">AIDA system administrator</a></span><span>, or by using the AIDA self-service </span><span class="c9"><a class="c2" href="#h.wy3qtdodds44">file sharing</a></span><span class="c0">&nbsp;service.</span></p><h2 class="c13" id="h.twa5knd31zt8"><span>Support to </span><span class="c18">ethical review applications in research</span></h2><p class="c7"><span>AIDA can give support to researchers in drafting ethical review applications that cover data sharing in medical imaging diagnostics. </span><span class="c9"><a class="c2" href="#h.4aw4xog2wvsp">Appendix 2</a></span><span>&nbsp;holds some suggestions on language that can be used. Researchers are welcome to </span><span class="c9"><a class="c2" href="mailto:aida-data-director@medtech4health.se">contact AIDA</a></span><span class="c0">&nbsp;with any questions relating to this matter.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>An approved ethical review application defines the framework for what is allowed activities in most research on humans and personal data. </span><span class="c9"><a class="c2" href="#h.6t1pdq248vyk">Appendix 1</a></span><span>&nbsp;discusses the legal/ethical context around this. Applications are submitted in Swedish to the </span><span>Swedish Ethical Review Authority</span><span>&nbsp;(&quot;etikpr&ouml;vningsmyndigheten&quot;, </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://etikprovningsmyndigheten.se/&amp;sa=D&amp;ust=1576784592137000">EPM</a></span><span class="c0">). The mechanisms for submission have varied. Some of the sections are relevant for data sharing. </span></p><h2 class="c13" id="h.451bq2n1myw"><span>Facilitating data sharing outside of AIDA</span></h2><p class="c7"><span class="c0">AIDA can support researchers who as copyright holders wish to share their research data outside of AIDA, and can facilitate contacts between data requesters and copyright holders for data sharing options outside of AIDA. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">AIDA can facilitate data transfers from AIDA systems to recipients based on instructions from the copyright holder. AIDA can also advise and share tools for data sharing.</span></p><hr style="page-break-before:always;display:none;"><p class="c3"><span class="c0"></span></p><h1 class="c19" id="h.6t1pdq248vyk"><span class="c27">Appendix 1 <br>Discussion on law, ethics and the common practice in the use of clinical imaging data for research in Sweden</span></h1><p class="c7"><span>The legal and ethical framework surrounding the use of personal data in research is complex. Much depends on the specifics of the particular details and the context surrounding each individual case, suggesting that it would be more appropriate to give recommendation on a case-by-case basis than for a hypothetical general case. Therefore, this is not an in-depth analysis of the framework, but a limited and superficial one. In the interest of readability, many potentially important considerations such as secrecy, law enforcement and national security have been left out of this discussion, although they may be very important to whatever case you as the reader may currently have in mind. Likewise, depending on circumstances, there may exist venues for legal and ethical research that are not covered in full here, such as </span><span>consented data collection, </span><span class="c0">clinical studies approved by the medical product agency, medical examinations as part of the ethically approved research activities, or through biobanking or register based research.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">This section is a discussion on the ethical/legal framework around the common practice in the use of clinical imaging data for research in Sweden, with reference to official sources which may be useful as starting points for someone looking to understand the framework, that they may become better equipped to evaluate their own engagements.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">This discussion is based on European law, and Swedish law in places where European law leaves room for national legislation. Researchers in countries similar to Sweden may likely be able to use this document as a point of departure for their own discussions, and may have similar legislation that can be used in places where this document references Swedish law.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c6">Note</span><span class="c0">: This document does not constitute legal advice.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">In Sweden the use of clinical data in research is regulated by:</span></p><ul class="c14 lst-kix_f2z71wooa743-0 start"><li class="c7 c10"><span>Dataskyddsf&ouml;rordningen (</span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/&amp;sa=D&amp;ust=1576784592141000">GDPR</a></span><span class="c0">): European General Data Protection Regulation.</span></li><li class="c7 c10"><span>Patientdatalagen (</span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/patientdatalag-2008355_sfs-2008-355&amp;sa=D&amp;ust=1576784592142000">PDL</a></span><span class="c0">): Patient data law.</span></li><li class="c7 c10"><span>Tryckfrihetsf&ouml;rordningen (</span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/tryckfrihetsforordning-1949105_sfs-1949-105&amp;sa=D&amp;ust=1576784592143000">TF</a></span><span class="c0">): Freedom of the press act.</span></li><li class="c7 c10"><span>Offentlighets- och sekretesslagen (</span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/offentlighets--och-sekretesslag-2009400_sfs-2009-400&amp;sa=D&amp;ust=1576784592143000">OSL</a></span><span class="c0">): Public access to information and secrecy act.</span></li><li class="c7 c10"><span>Etikpr&ouml;vningslagen (</span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/lag-2003460-om-etikprovning-av-forskning-som_sfs-2003-460&amp;sa=D&amp;ust=1576784592144000">EPL</a></span><span class="c0">): Ethical review act.</span></li><li class="c7 c10"><span>Upphovsr&auml;ttslagen (</span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/lag-1960729-om-upphovsratt-till-litterara-och_sfs-1960-729&amp;sa=D&amp;ust=1576784592145000">URL</a></span><span class="c0">): Copyright law.</span></li><li class="c7 c10"><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/lag-2019504-om-ansvar-for-god-forskningssed_sfs-2019-504&amp;sa=D&amp;ust=1576784592145000">Lag om ansvar f&ouml;r god forskningssed och pr&ouml;vning av oredlighet i forskning</a></span><span class="c0">: Good research practice and review of research misconduct act.</span></li><li class="c7 c10"><span class="c0">Institutional policies, describing how institutions shall act and operate in order to uphold for example ethics, privacy and data protection obligations.</span></li></ul><p class="c3"><span class="c0"></span></p><p class="c7"><span>Explicitly, the Swedish </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/lag-2002297-om-biobanker-i-halso--och_sfs-2002-297&amp;sa=D&amp;ust=1576784592146000">biobank law</a></span><span>&nbsp;does not regulate the use of clinical data in research, but rather concerns the use and </span><span>keeping</span><span>&nbsp;of physical human biological materials, and defines rules that are much more strict than the above laws that regulate data processing. The possible reason is that a tissue sample can </span><span>potentially</span><span class="c0">&nbsp;be analysed in a myriad ways that could give rise to a potentially huge amount of sensitive personal data, whose consequences of disclosure could be very hard to assess.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The General Data Protection Regulation (GDPR) is the law that regulates all processing of personal data in all of Europe, which according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%234&amp;sa=D&amp;ust=1576784592148000">GDPR Article 4 &sect;2</a></span><span>&nbsp;includes a very broad range of activities such as collection, organisation, storage, alteration, retrieval, use, disclosure, alignment, restriction, or even erasure and destruction of data.</span><span>&nbsp;</span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%236&amp;sa=D&amp;ust=1576784592148000">GDPR Article 6 &sect;1</a></span><span>&nbsp;requires all processing of personal information to have a legal basis and be for a specified purpose, and </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%235&amp;sa=D&amp;ust=1576784592149000">GDPR Article 5 &sect;1 b</a></span><span>&nbsp;states that further processing for research is not to be seen as incompatible with any initially defined purposes</span><span>. However, most data from medical imaging concerns information on the health of a natural person, which is a special category of information given special protection by </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%239&amp;sa=D&amp;ust=1576784592150000">GDPR Article 9 &sect;1</a></span><span>, which states that processing these categories of information is forbidden, except in a defined set of circumstances</span><span class="c0">. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%239&amp;sa=D&amp;ust=1576784592151000">GDPR Article 9 &sect;3</a></span><span>&nbsp;allows caregivers to process patient data according to national law, which in the case of Sweden is the Swedish patient data law (PDL). </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/patientdatalag-2008355_sfs-2008-355%23K3P1&amp;sa=D&amp;ust=1576784592151000">PDL Chapter 3 &sect;1</a></span><span>&nbsp;requires caregivers to maintain patient health records (&quot;patientjournal&quot;), and </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/patientdatalag-2008355_sfs-2008-355%23K2P6&amp;sa=D&amp;ust=1576784592152000">PDL Chapter 2 &sect;6</a></span><span>&nbsp;as well as </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%234&amp;sa=D&amp;ust=1576784592152000">GDPR Article 4 &sect;7</a></span><span>&nbsp;identifies</span><span>&nbsp;the caregiver as </span><span>data controller</span><span>&nbsp;(&quot;personuppgiftsansvarig&quot;) to these records. These records may be electronic, and may be distributed over several systems (eg </span><span>PACS, LIS</span><span>, etc). </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/patientdatalag-2008355_sfs-2008-355%23K3P2&amp;sa=D&amp;ust=1576784592153000">PDL Chapter 3 &sect;2</a></span><span class="c0">&nbsp;identifies these records as a source of information for research. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>Swedish freedom of the press act (&quot;tryckfrihetsf&ouml;rordningen&quot;) </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/tryckfrihetsforordning-1949105_sfs-1949-105%23K2P4&amp;sa=D&amp;ust=1576784592154000">TF Chapter 2 &sect;4</a></span><span>&nbsp;states that documents at a public authority (&quot;myndighet&quot;, eg a caregiver) are public, and </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/tryckfrihetsforordning-1949105_sfs-1949-105%23K2P1&amp;sa=D&amp;ust=1576784592155000">TF Chapter 2 &sect;1</a></span><span>&nbsp;states that all shall have the right to access them, unless according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/tryckfrihetsforordning-1949105_sfs-1949-105%23K2P2&amp;sa=D&amp;ust=1576784592155000">TF Chapter 2 &sect;2</a></span><span>&nbsp;access must be restricted for example on account of individual privacy. &nbsp;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%239&amp;sa=D&amp;ust=1576784592156000">GDPR Article 9 &sect;2 g</a></span><span>&nbsp;allows research processing of such information according to national law, if it is pursuing a substantial public interest, is proportional to the aim, and has adequate </span><span>protections in place</span><span>&nbsp;according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%2332&amp;sa=D&amp;ust=1576784592157000">GDPR Article 32</a></span><span>&nbsp;and </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%2389&amp;sa=D&amp;ust=1576784592157000">GDPR Article 89</a></span><span>. In Sweden this is established according to the Swedish ethical review act (eg &quot;etikpr&ouml;vningslagen&quot;) </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/lag-2003460-om-etikprovning-av-forskning-som_sfs-2003-460%23P6&amp;sa=D&amp;ust=1576784592158000">EPL &sect;6</a></span><span>&nbsp;in an application for review to the Swedish Ethical Review Authority (&quot;etikpr&ouml;vningsmyndigheten&quot;, </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://etikprovningsmyndigheten.se/&amp;sa=D&amp;ust=1576784592158000">EPM</a></span><span>). An approved ethical review application then gives the framework for the research activity in terms of what data processing is allowed, and what safeguards are to be employed (cf </span><span class="c9"><a class="c2" href="#h.jqg9p3qlo7q">Protective measures</a></span><span class="c0">&nbsp;below). This framework can be modified by submitting an amendment application (&quot;&auml;ndringsans&ouml;kan&quot;) to EPM, if needed for example to get support for further kinds of processing.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The ethical review application specifies the legal entity under whose control the research activities will be carried out (&quot;research institution&quot;, cf </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/lag-2003460-om-etikprovning-av-forskning-som_sfs-2003-460%23P2&amp;sa=D&amp;ust=1576784592159000">EPL &sect;2</a></span><span>&nbsp;&quot;forskningshuvudman&quot;). In Sweden this is nearly always an organization, such as a university or a company. </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/lag-2003460-om-etikprovning-av-forskning-som_sfs-2003-460%23P11&amp;sa=D&amp;ust=1576784592160000">EPL &sect;11</a></span><span>&nbsp;allows research only if it is carried out by or under supervision by a researcher who has the necessary scientific competencies</span><span>, which includes the awareness and ability to ensure that the activities are carried out as described in the ethical review application and according to institutional policies at the research institution</span><span>. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>According to Swedish public access to information and secrecy act (&quot;offentlighets- och sekretesslag&quot;) </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/offentlighets--och-sekretesslag-2009400_sfs-2009-400%23K6P4&amp;sa=D&amp;ust=1576784592161000">OSL Chapter 6 &sect;4</a></span><span>&nbsp;caregivers shall on request disclose the documents (&quot;l&auml;mna ut handlingarna&quot;) to the research institution, </span><span>unless </span><span>for example according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/offentlighets--och-sekretesslag-2009400_sfs-2009-400%23K21P7&amp;sa=D&amp;ust=1576784592162000">OSL Chapter 21 &sect;7</a></span><span>&nbsp;it can be assumed that the disclosed information will be processed in breach of EPL. </span><span>This means that the caregiver must not disclose information outside of what is described in the approved ethical review application, nor if it can be assumed that the recipient will abuse the disclosed information for example by processing it by means or for purposes other than what is described in the approved ethical review application.</span><span>&nbsp;Also, </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/offentlighets--och-sekretesslag-2009400_sfs-2009-400%23K25P1&amp;sa=D&amp;ust=1576784592162000">OSL Chapter 25 &sect;1</a></span><span>&nbsp;and </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/offentlighets--och-sekretesslag-2009400_sfs-2009-400%23K21P1&amp;sa=D&amp;ust=1576784592163000">OSL Chapter 21 &sect;1</a></span><span>&nbsp;require the caregiver to assess whether disclosure could harm an individual (&quot;menpr&ouml;vning&quot;). This should take into account that research institutions that are public authorities (such as universities) are also required by OSL to assess harm before any subsequent disclosure, whereas private companies </span><span>are not</span><span class="c0">. Such assessments are typically carried out with support from internal institutional policies and guidelines for information classification and management.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">If the caregiver discloses personal information for use in research activities under a research institution&#39;s control as described in the approved ethical review application, then the research institution becomes data controller to the disclosed information, and is from then on responsible for the legal and ethical processing and safeguarding of the disclosed information. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The research institution can according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%2328&amp;sa=D&amp;ust=1576784592165000">GDPR Article 28 &sect;3</a></span><span>&nbsp;also make use of third party services for processing personal data (cf </span><span class="c9"><a class="c2" href="#h.yqn6rdkzu3no">Data processing services, and the cloud</a></span><span>&nbsp;below</span><span class="c0">). </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The research institution also has the copyright (&quot;upphovsr&auml;tt&quot;) to the disclosed information according to Swedish copyright law (&quot;upphovsr&auml;ttslagen&quot;) </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/lag-1960729-om-upphovsratt-till-litterara-och_sfs-1960-729%23K5P49&amp;sa=D&amp;ust=1576784592166000">URL &sect;4</a></span><span class="c9">9</span><span>, because it has &quot;produced a catalog, table or similar into which large quantities of information have been put together&quot;, since the data extraction is carried out according to parameters specified in the approved ethical review application. If the approved ethical review application allows, the research institution can also grant use of the information to others, and can use licensing terms (&quot;avtalslicens&quot;) to further limit what use is to be considered allowed according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/lag-1960729-om-upphovsratt-till-litterara-och_sfs-1960-729%23K3a&amp;sa=D&amp;ust=1576784592167000">URL Chapter 3a</a></span><span class="c0">.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>Starting 2020-01-01, </span><sup><a href="#cmnt2" id="cmnt_ref2">[b]</a></sup><span>the research institution will then be required to store the information for 10 years after last use, in order to enable research validation according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/lag-2019504-om-ansvar-for-god-forskningssed_sfs-2019-504%23P8&amp;sa=D&amp;ust=1576784592168000">&sect;8</a></span><span class="c0">&nbsp;of Swedish Good research practice and review of research misconduct act (&quot;lag om ansvar f&ouml;r god forskningssed och pr&ouml;vning av oredlighet i forskning&quot;).</span></p><h2 class="c13" id="h.yqn6rdkzu3no"><span class="c18">Data processing services, and the cloud</span></h2><p class="c7"><span>The research institution can make use of third party services also for processing personal data according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%2328&amp;sa=D&amp;ust=1576784592169000">GDPR Article 28 &sect;3</a></span><span>&nbsp;if a data processing agreement (&quot;personuppgiftsbitr&auml;desavtal&quot;) is in place which describes what processing is allowed, however such an agreement may according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%2328&amp;sa=D&amp;ust=1576784592170000">GDPR Article 28 &sect;1</a></span><span>&nbsp;only be made with a data processor (&quot;personuppgiftsbitr&auml;de&quot;) that can provide sufficient guarantees that appropriate technical and organisational measures are put in place (cf </span><span class="c9"><a class="c2" href="#h.jqg9p3qlo7q">Protective measures</a></span><span>&nbsp;below). The data processor may also according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%2328&amp;sa=D&amp;ust=1576784592171000">GDPR Article 28 &sect;3 a</a></span><span>&nbsp;only process information according to documented instruction from the data controller. According to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%2382&amp;sa=D&amp;ust=1576784592171000">GDPR Article 82 &sect;2</a></span><span class="c0">&nbsp;the data controller is liable for any damages caused by this processing, however the data processor is liable for damage caused by any processing it has carried out outside of these instructions. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">In regards to sufficient guarantees, it may be easier for a research institution in the EU to obtain such guarantees from data processors that are based in the EU (or even in the same country) and as such themselves are regulated by GDPR, keeping in mind that data processors based outside the EU may not be legally allowed to fulfill any guarantees given, depending on national legislation in the country where they are based, and that a research institution in the EU may not have the same ability to successfully pursue legal action in countries outside the EU in case of failure to uphold these guarantees. </span></p><h2 class="c13" id="h.jqg9p3qlo7q"><span class="c18">Protective measures</span></h2><p class="c7"><span>Principles for protection shall according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%235&amp;sa=D&amp;ust=1576784592173000">GDPR Article 5 &sect;1</a></span><span class="c0">&nbsp;include purpose limitation (only for specified legal purposes), data minimization (only use relevant and necessary data), storage minimization (do not keep longer than necessary), and integrity and confidentiality (technical and organizational measures). </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%2332&amp;sa=D&amp;ust=1576784592174000">GDPR Article 32 &sect;1</a></span><span>&nbsp;requires data controllers to implement appropriate technical and organisational measures to ensure a level of security appropriate to the risk, taking into account the state of the art, the costs of implementation and the nature, scope, context and purposes of processing as well as the risk of varying likelihood and severity for the rights and freedoms of natural persons. The preceding sentence contains many qualifiers that are hard to quantify objectively, like &quot;appropriate&quot;, &quot;taking into account&quot;, &quot;state of the art&quot;, &quot;cost&quot;, &quot;nature&quot;, &quot;risk&quot;, &quot;likelihood&quot;, and &quot;severity&quot;. Advise on their interpretation is provided by national supervisory authorities (&quot;tillsynsmyndighet&quot;, </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/&amp;sa=D&amp;ust=1576784592175000">Datainspektionen</a></span><span>&nbsp;in Sweden) according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%2357&amp;sa=D&amp;ust=1576784592175000">GDPR Article 57 &sect;1c</a></span><span>, and by data protection officers (&quot;dataskyddsombud&quot;) at large organizations such as public authorities (&quot;myndighet&quot;) according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%2339&amp;sa=D&amp;ust=1576784592176000">GDPR Article 39 &sect;1</a></span><span class="c0">, for example through institutional policies or on request. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%2332&amp;sa=D&amp;ust=1576784592176000">GDPR Article 32 &sect;1a</a></span><span>&nbsp;suggests encryption and/or pseudonymization when suitable. Pseudonymization, according to </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%234&amp;sa=D&amp;ust=1576784592177000">GDPR Article 4 &sect;5</a></span><span>&nbsp;entails processing of personal data in such a manner that it can no longer be attributed to a specific person, without the use of additional information (eg &quot;a key&quot;) which is to be kept protected and separate. If this additional information is deleted, so that it is no longer possible to attribute the data to a specific person even indirectly, then the data is anonymous and ceases to be personal data regulated by GDPR, and thus may no longer require as high levels of protection. </span><span>However, </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://www.datainspektionen.se/lagar--regler/dataskyddsforordningen/dataskyddsforordningen---fulltext/%2332&amp;sa=D&amp;ust=1576784592178000">GDPR Article 32 &sect;1d</a></span><span>&nbsp;requires regular follow-up of the effectiveness of the protective measures, such as anonymization carried out in the past, since as the &quot;state of the art&quot; progresses and more information becomes available, it may over time become possible or even trivial to again attribute the data to a specific person, making the data anonymous no longer. Depending on how the supposedly anonymous data has been disseminated, it may then require significant effort across many organizations to again restore it to an appropriate level of protection.</span><span class="c0">&nbsp;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>As can be seen in this and the preceding section, despite detailed data protection guidelines and support functions, many of the implementational details are still left to the individual researcher to resolve. This is in no insignificant part due to the nature of research itself, whose mission it is to investigate the unclear and to learn the unknown, which makes it hard for anyone to usefully advise the researcher on how best to process the data that they themselves are the most intimately acquainted with and </span><span>our</span><span class="c0">&nbsp;foremost experts on.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>Researchers can to some degree find support from data protection officers and in policy documents such as this, and in the approval of ethical review applications that they themselves likely wrote, but detailed questions like &quot;</span><span>can this data be considered anonymous</span><span class="c0">?&quot;, and &quot;are these protective measures appropriate?&quot; must by necessity be answered finally by the researchers themselves. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">There are however two encouraging consequences arising from this: while the ethical/legal framework surrounding these activities is complex, most research is actually allowed if only it can be properly motivated. And the obvious corollary: if it cannot, then it is not. </span></p><hr style="page-break-before:always;display:none;"><h1 class="c8" id="h.agrg52jun4in"><span class="c27"></span></h1><hr style="page-break-before:always;display:none;"><h1 class="c8" id="h.4aw4xog2wvsp"><span class="c27"></span></h1><h1 class="c19" id="h.jq11ducoq2g1"><span>Appendix 2</span><span class="c27">&nbsp;<br>Examples of language in ethical review applications to support data sharing in research</span></h1><p class="c7"><span class="c0">AIDA can give support to researchers in drafting ethical review applications that cover data sharing in medical imaging diagnostics. This section holds suggestions on language that can be used. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">These phrases are all taken out of their respective contexts where they describe circumstances and appropriate protective measures in their respective research activities. They are not intended to be used as-is, but likely need to be adapted to specific circumstances in new ethical review applications. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>Researchers are welcome to </span><span class="c9"><a class="c2" href="mailto:aida-data-director@medtech4health.se">contact AIDA</a></span><span class="c0">&nbsp;with any questions relating to this matter.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>An approved ethical review application defines the framework for what is allowed activities in most research on humans and personal data. Some of the sections are relevant for data sharing. </span><span class="c9"><a class="c2" href="#h.6t1pdq248vyk">Appendix 1</a></span><span>&nbsp;discusses the legal/ethical context around this. Applications are submitted to the </span><span>Swedish Ethical Review Authority</span><span>&nbsp;(&quot;etikpr&ouml;vningsmyndigheten&quot;, </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://etikprovningsmyndigheten.se/&amp;sa=D&amp;ust=1576784592183000">EPM</a></span><span>). The mechanisms for submission have varied. At the time of writing an online processing system is being replaced, so in the interim </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://etikprovningsmyndigheten.se/&amp;sa=D&amp;ust=1576784592183000">forms</a></span><span class="c0">&nbsp;for manual processing. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Applications to EPM are processed in Swedish, but for the benefit of non-Swedish speaking readers, a translation to English is available at the end of this appendix.</span></p><h2 class="c13" id="h.jzyk2celmez6"><span class="c18">Examples</span></h2><h3 class="c17" id="h.if7j0qxngvl"><span class="c11">Relevanta avdelningar</span></h3><ul class="c14 lst-kix_szyv2fwd9a7b-0 start"><li class="c7 c10"><span class="c0">6. Datainsamling</span></li></ul><ul class="c14 lst-kix_szyv2fwd9a7b-1 start"><li class="c7 c16"><span class="c0">6.4 Hur kommer insamlad data att hanteras och f&ouml;rvaras?</span></li></ul><ul class="c14 lst-kix_szyv2fwd9a7b-0"><li class="c7 c10"><span class="c0">7. Etiska &ouml;verv&auml;ganden</span></li></ul><ul class="c14 lst-kix_szyv2fwd9a7b-1 start"><li class="c7 c16"><span class="c0">7.1 Vilka risker kan ett deltagande medf&ouml;ra f&ouml;r de forskningspersoner som ing&aring;r i forskningsprojektet?</span></li><li class="c7 c16"><span class="c0">7.2 Vilken nytta kan ett deltagande medf&ouml;ra f&ouml;r de forskningspersoner som ing&aring;r i forskningsprojektet?</span></li><li class="c7 c16"><span class="c0">7.4 Beskriv hur projektet har utformats f&ouml;r att minimera riskerna f&ouml;r forskningspersonerna</span></li></ul><ul class="c14 lst-kix_szyv2fwd9a7b-0"><li class="c7 c10"><span class="c0">9. Information och samtycke</span></li></ul><ul class="c14 lst-kix_szyv2fwd9a7b-1 start"><li class="c7 c16"><span class="c0">9.1 Kommer forskningspersonerna att informeras om forskningsprojektet och tillfr&aring;gas om de vill vara med eller inte?</span></li></ul><ul class="c14 lst-kix_szyv2fwd9a7b-2 start"><li class="c7 c29"><span class="c0">9.1.2 Motivera varf&ouml;r forskningspersonerna inte ska informeras och tillfr&aring;gas</span></li></ul><ul class="c14 lst-kix_szyv2fwd9a7b-0"><li class="c7 c10"><span class="c0">10. Registeruppgifter</span></li></ul><ul class="c14 lst-kix_szyv2fwd9a7b-1 start"><li class="c7 c16"><span class="c0">10.1 Kommer projektet att beg&auml;ra ut uppgifter fr&aring;n ett befintligt register?</span></li></ul><ul class="c14 lst-kix_szyv2fwd9a7b-2 start"><li class="c7 c29"><span class="c0">10.1.2 Vilka uppgifter kommer att beg&auml;ras ut och varf&ouml;r?</span></li></ul><ul class="c14 lst-kix_szyv2fwd9a7b-0"><li class="c7 c10"><span class="c0">13. Redovisning av resultat</span></li></ul><ul class="c14 lst-kix_szyv2fwd9a7b-1 start"><li class="c7 c16"><span class="c0">13.1 Hur garanteras tillg&aring;ng till data f&ouml;r forskningshuvudmannen och medverkande forskare?</span></li><li class="c7 c16"><span class="c0">13.2 Vem eller vilka ansvarar f&ouml;r databearbetning och skriftlig redovisning av resultaten?</span></li><li class="c7 c16"><span class="c0">13.3 Hur och n&auml;r planeras resultaten att offentligg&ouml;ras?</span></li><li class="c7 c16"><span class="c0">13.4 P&aring; vilket s&auml;tt garanteras forskningspersonernas r&auml;tt till integritet n&auml;r materialet offentligg&ouml;rs?</span></li></ul><h3 class="c17" id="h.tbbf4snf6p9m"><span class="c11">Datam&auml;ngder</span></h3><p class="c7"><span class="c0">&quot;Den statistiska styrkan avg&ouml;r det f&ouml;rv&auml;ntade antalet signifikanta resultat och &auml;r relaterad till sannolikheten att ett visst signifikant resultat reflekterar en sann effekt. Inom OMR&Aring;DE vet vi nu att om vi &ouml;kar antalet patienter med N nya fall, s&aring; leder det till U-V nya signifikanta fynd. Om vi dubblerar storleken p&aring; TIDIGARE_STUDIE, s&aring; b&ouml;r vi d&aring; identifiera X-Y nya M&Ouml;JLIGA_ORSAKER till SJUKDOM, vilket skulle inneb&auml;ra ett viktigt bidrag med ny kunskap om den underliggande etiologin bakom SJUKDOM.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Antalet bilder som kommer att extraheras relateras till den power och relevans som avses per studie och vi &ouml;nskar kunna g&ouml;ra ett bra randomiserat urval varf&ouml;r antalet tar h&ouml;jd f&ouml;r STORT_ANTAL bilder baserat p&aring; den digitala 5 &aring;rsproduktion som finns i det digitala arkivet (totalt cirka V&Auml;SENTLIGT_ST&Ouml;RRE_ANTAL bilder).&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;M&aring;nga s&auml;tter idag sin tilltro till att olika st&ouml;dsystem baserade p&aring; artificiell intelligens (AI) ska kunna erbjuda OMR&Aring;DE en hj&auml;lp att b&aring;de effektivisera och f&ouml;rb&auml;ttra kvalit&eacute;ten i YRKESVERKSAMMAS arbete. En utmaning i sammanhanget &auml;r att den tr&auml;ningsdata som beh&ouml;vs f&ouml;r att utveckla AI-system f&ouml;r dessa syften &auml;r kraftigt begr&auml;nsad, om ens tillg&auml;nglig. Detta projekt syftar till att utveckla och publicera en &ouml;ppen bilddatabas inneh&aring;llande detaljerade annoteringar f&ouml;r tr&auml;ning av AI-system till st&ouml;d f&ouml;r den bilddiagnostik som genomf&ouml;rs av YRKESVERKSAMMA i samband med diagnos och uppf&ouml;ljning av patienter inom OMR&Aring;DE.&quot;</span></p><h3 class="c17" id="h.mhbnsddbr895"><span class="c11">Riskminimering </span></h3><h4 class="c25" id="h.2obk3aa9o4c3"><span class="c26">Sekretess</span></h4><p class="c7"><span class="c0">&quot;Alla nyanst&auml;llda p&aring; HUVUDMAN skriver p&aring; avtal om sekretess och tystnadsplikt.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Personal som kommer i kontakt med data ger skriftlig f&ouml;rs&auml;kran att inte i n&aring;got sammanhang bryta sekretessbest&auml;mmelser.&quot;</span></p><h4 class="c25" id="h.t84fyd663dl3"><span class="c26">Ansvar och kompetens</span></h4><p class="c7"><span class="c0">&quot;NAMNGIVEN_FORSKARE, ROLL vid HUVUDMAN, har ansvaret f&ouml;r forskningspersonernas s&auml;kerhet, vilket i detta projekt inneb&auml;r att resurser finns f&ouml;r att hantera projektet enligt plan med avseende p&aring; anonymisering och s&auml;kerhet etc. Se intyg i BILAGA.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Forskningen genomf&ouml;rs under ansvar av prefekten vid INSTITUTION, HUVUDMAN. Vid INSTITUTION finns n&ouml;dv&auml;ndiga resurser och expertis f&ouml;r att s&auml;kerst&auml;lla forskningspersonernas s&auml;kerhet och integritet (datasekretess) samt forskningsprojektets genomf&ouml;rande, se BILAGA&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Deltagarnas integritet skyddas utifr&aring;n ett strukturerat informationss&auml;kerhetsarbete enligt ISO 27000. Detta inneb&auml;r att arbetet styrs av policies, riktlinjer samt ett medvetande hos personalen.&quot;</span></p><h4 class="c25" id="h.qy9bkchn39xr"><span class="c26">&Aring;tkomstbegr&auml;nsning</span></h4><p class="c7"><span class="c0">&quot;Inga obeh&ouml;riga &auml;ger tilltr&auml;de till lokalerna (passerkort och kod) d&auml;r data och material lagras. F&ouml;r HUVUDMANs lokaler g&auml;ller s&auml;rskild beh&ouml;righet.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Ingen data lagras lokalt. All data lagras centralt i en serverhall vid HUVUDMAN. Serverhallen skyddas enligt g&auml;ngse normer f&ouml;r skalskydd. Alla uppkopplingar till den centrala serverhallen sker via krypterade kommunikationsf&ouml;rbindelser.&quot;</span></p><h4 class="c25" id="h.l5z1t3cy3jeu"><span class="c26">Begr&auml;nsning till mindre k&auml;nsliga datatyper</span></h4><p class="c7"><span class="c0">&quot;Data som beskriver YRKESVERKSAMMAS arbetss&auml;tt kommer att samlas in. Dessa kommer att vara tillg&auml;ngliga bara f&ouml;r forskare i projektet och bara publiceras i anonym form.&quot;</span></p><h4 class="c25" id="h.k7lav71znfk7"><span class="c26">Begr&auml;nsning till enbart data</span></h4><p class="c7"><span class="c0">&quot;Inga avvikelser fr&aring;n klinisk rutin eller ordinarie behandling kommer att ske inom projektet.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Ang&aring;ende tidigare erfarenheter av den anv&auml;nda behandlingen: &quot;Ej relevant, eftersom projektet inte direkt kommer leda till n&aring;gon &auml;ndring eller n&aring;got till&auml;gg till patienternas v&aring;rd.&quot;</span></p><h4 class="c25" id="h.n4iwafkgpm0e"><span class="c26">Deltagande i flera projekt</span></h4><p class="c7"><span class="c0">&quot;Eftersom v&aring;r studie &auml;r en observationell studie och inte en interventionsstudie, s&aring; l&ouml;per inte forskningspersonerna st&ouml;rre risker om denna observationsstudie kombineras med en annan forskningstudie.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Flera studier kan utnyttja data fr&aring;n projektet men forskningspersonerna p&aring;verkas inte av detta eftersom dessa studier inte medf&ouml;r f&ouml;rnyad kontakt med deltagarna.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Ej relevant, forskningspersonerna l&ouml;per ingen risk genom att vara del av detta projekt, varf&ouml;r kombinationseffekter med andra projekt inte kommer uppst&aring;.&quot;</span></p><p class="c3"><span class="c0"></span></p><h4 class="c25" id="h.jibkole80hrr"><span class="c26">Teknik</span></h4><p class="c7"><span class="c0">&quot;Krypteringsnycklar skickas separat och med oberoende &ouml;verf&ouml;ringsmetod.&quot;</span></p><h3 class="c17" id="h.xvv4qloei5cv"><span class="c11">L&auml;nkad data fr&aring;n flera k&auml;llor</span></h3><p class="c7"><span class="c0">&quot;Data kommer skickas med personnummer fr&aring;n DATAK&Auml;LLOR och l&auml;nkas, varefter data kommer pseudonymiseras.&quot; </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Personnummer m&aring;ste beh&aring;llas under datainsamlingsdelen av studien och d&auml;refter kommer bilderna och hela databasen att pseudonymiseras.&quot;</span></p><h3 class="c17" id="h.8nnz0gjxndct"><span class="c11">Pseudonym data</span></h3><p class="c7"><span class="c0">&quot;Alla data kommer att pseudonymiseras och ges slumpm&auml;ssiga kodnummer, som inte kan kopplas till personernas identitet. Kodnyckel som kopplar samman kod till personers identitet kommer endast att finnas vid HUVUDMAN.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Lagringen av data sker s&aring; att enskilda individer ej &auml;r identifierbara annat &auml;n av forskargruppen.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Skriftliga dokument f&ouml;rvaras l&aring;sta och med kodnummer.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Databaserad information kopplas till kodnummer och kan inte avsl&ouml;ja personernas identitet.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Resultaten sammanst&auml;lls i tabeller d&auml;r inga enskilda individer kan identifieras.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Pseudonyma uppgifter SPECIFIKATION kommer lagras i DATABAS eller liknande inom EU/EES och i enlighet med GDPR. Data i denna databas kommer att kunna anv&auml;ndas och analyseras av forskargrupper i Sverige och utomlands. F&ouml;r att f&aring; tillg&aring;ng till data m&aring;ste forskare ans&ouml;ka om ett uttag och beskriva hur data ska anv&auml;ndas (vilket m&aring;ste vara i linje med denna ans&ouml;kan).&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;S&auml;kerheten garanteras genom att deltagaren loggar in med e-legitimation (BankID) samt att s&auml;kra datorprotokoll (https) anv&auml;nds.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Avidentifierade data kommer att analyseras av ansvarig forskare samt medverkande forskare.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Pseudonymiseringsnyckeln kommer krypteras och f&ouml;rvaras hos HUVUDMAN, &aring;tkomligt enbart f&ouml;r senior ledning i forskningsprojektet. Tillh&ouml;rande krypteringsnyckel kommer f&ouml;rvaras inl&aring;st i kassask&aring;p hos HUVUDMAN. Data i pseudonym form kommer att behandlas och delas p&aring; system avsedda f&ouml;r behandling av k&auml;nsliga personuppgifter i enlighet med GDPR, och kommer sparas f&ouml;r att m&ouml;jligg&ouml;ra forskningsvalidering. Pseudonym data som ej l&auml;ngre beh&ouml;vs kommer att anonymiseras eller gallras. Data i anonym form kommer att publiceras och delas f&ouml;r att m&ouml;jligg&ouml;ra vidare beforskning.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Data i pseudonym form kommer att behandlas och delas p&aring; lokala IT-system enligt HUVUDMANs rutiner, och p&aring; nationella system speciellt konstruerade f&ouml;r behandling av k&auml;nsliga personuppgifter i forskningssyfte i enlighet med GDPR, s&aring;som SNIC-SENS Bianca.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Om andra forskare vill granska datat och reproducera resultaten kommer de erbjudas tillg&aring;ng till pseudonym eller anonym data under icke-spridningsavtal, antingen p&aring; plats vid HUVUDMAN eller med hj&auml;lp av nationella system speciellt konstruerade f&ouml;r behandling av k&auml;nslig persondata f&ouml;r forskning i enlighet med GDPR.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Vid presentation av resultat kommer dessa att vara avidentifierade och om individuella resultat presenteras kommer dessa inte vara kopplade till identifierbar information. Resultaten kommer huvudsakligen redovisas p&aring; aggregerad niv&aring;.&quot;</span></p><h3 class="c17" id="h.ywcb8xospw6v"><span class="c11">Anonym data</span></h3><p class="c7"><span class="c0">&quot;Patienterna informeras ej om forskningsprojektet. De ans&ouml;kande forskarna drar slutsatsen att detta inte beh&ouml;vs, eftersom personuppgifter inte hanteras.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Samtycke inh&auml;mtas inte fr&aring;n patienterna. De ans&ouml;kande forskarna drar slutsatsen att detta inte beh&ouml;vs, eftersom personuppgifter inte hanteras.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Projektet medf&ouml;r inga risker f&ouml;r deltagarna. Patienterna p&aring;verkas inte av projektet.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Projektet tillf&ouml;r ingen direkt nytta f&ouml;r forskningspersonerna. Patienterna p&aring;verkas inte av projektet. Yrkesverksamma deltagare f&aring;r inte direkt nytta, men kan i framtiden dra nytta av resultat i form av f&ouml;rb&auml;ttrade verktyg och arbetss&auml;tt.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Inga etiska problem. F&ouml;rhoppningsvis kan forskningen indirekt leda till f&ouml;rb&auml;ttrad framtida v&aring;rd.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Ang&aring;ende forskningspersonernas r&auml;tt till integritet: &quot;Ej relevant f&ouml;r patienterna. Personuppgifter fr&aring;n patienterna kommer aldrig behandlas i forskningen eftersom f&ouml;rsta steget &auml;r full anonymisering.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Insamlingen och avidentifieringen kommer att ske genom en halvautomatisk procedur. En beh&ouml;rig individ kommer sk&ouml;ta insamlingen inom sjukhusets n&auml;tverk. D&auml;refter kommer avidentifiering ske automatiskt, varp&aring; data kommer att lagras, under l&ouml;senordsskydd, och sedan g&ouml;ras tillg&auml;ngligt f&ouml;r forskare i projektet. De ans&ouml;kande forskarna drar slutsatsen att detta tillv&auml;gag&aring;ngss&auml;tt inneb&auml;r att projektets insamlade data fr&aring;n patienter inte utg&ouml;r personuppgifter i lagens mening eller &auml;r integritetsk&auml;nsliga och d&auml;rmed inte ber&ouml;rs av etikpr&ouml;vning.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Ans&ouml;kan g&auml;ller huvudsakligen data som samlats in p&aring; klinik av medicinska sk&auml;l, oberoende av forskningsstudien. Projektet hanterar inte personuppgifter fr&aring;n patienter, dvs data kan inte h&auml;rr&ouml;ras tillbaka till forskningspersonerna. S&aring;ledes kan projektet inte p&aring;verka patienterna p&aring; n&aring;got s&auml;tt, och d&auml;rf&ouml;r inte heller p&aring;verka deras s&auml;kerhet.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Data kommer att avidentifieras p&aring; s&aring;dant s&auml;tt att informationen inte kan &aring;terf&ouml;ras till den individ det h&auml;rstammar fr&aring;n. Information s&aring;som namn, personnummer och telefonnummer kommer att avl&auml;gsnas alternativt ers&auml;ttas med genererad data. &Auml;ven indirekt identifierande information, s&aring; som remiss- och unders&ouml;kningsnummer kommer att avl&auml;gsnas eller ers&auml;ttas.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Data extraheras ur det kliniska IT-systemet genom en automatisk procedur. Ett automatiskt program kommer inom sjukhusets n&auml;tverk att sk&ouml;ta detta, inklusive all anonymisering. Data kommer sedan att lagras anonymiserade. Anonymiserade bilddata kommer sedan att berikas med medicinska metadata, framf&ouml;r allt i form av annoteringar fr&aring;n medicinska experter &ouml;ver olika v&auml;vnadstyper och sjukdomsuttryck.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Anonymiserade data avses att publiceras och g&ouml;ras tillg&auml;nglig f&ouml;r andra forskare inom omr&aring;det f&ouml;r att ge m&ouml;jlighet till reproduktion av studien och d&auml;rmed &ouml;ka validiteten av metoden, och &auml;ven f&ouml;r att ge m&ouml;jlighet till deras egen forskning inom till exempel utveckling av bildanalysapplikationer.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Dataskydd &auml;r ej relevant, d&aring; projektet inte hanterar personuppgifter fr&aring;n patienter eller k&auml;nsliga uppgifter om medverkande yrkesverksamma.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Samtliga forskare har tillg&aring;ng till data och kommer alla bidra till databearbetning och publikationer, under huvudansvarig forskares ansvar.&quot;</span></p><h2 class="c13" id="h.5qvu5ayuqaib"><span class="c18">Examples translated to English</span></h2><p class="c7"><span class="c0">This is a non-professional translation to English of original phrases in Swedish, provided for the benefit of non-Swedish speaking readers. Please note that these phrases address evaluation criteria defined by the Swedish national ethical review authority based on circumstances in Sweden, and that criteria and circumstances may be different in other countries.</span></p><h3 class="c17" id="h.eilczfr0pu0z"><span class="c11">Relevant sections</span></h3><ul class="c14 lst-kix_m7ug533nwn28-0 start"><li class="c7 c10"><span class="c0">6. Data collection</span></li></ul><ul class="c14 lst-kix_m7ug533nwn28-1 start"><li class="c7 c16"><span class="c0">6.4 How will the collected data be handled and stored?</span></li></ul><ul class="c14 lst-kix_m7ug533nwn28-0"><li class="c7 c10"><span class="c0">7. Ethical considerations</span></li></ul><ul class="c14 lst-kix_m7ug533nwn28-1 start"><li class="c7 c16"><span class="c0">7.1 What are the risks that participation can entail for the participants in the research project?</span></li><li class="c7 c16"><span class="c0">7.2 What benefits can participation bring to the participants included in the research project?</span></li><li class="c7 c16"><span class="c0">7.4 Describe how the project was designed to minimize the risks to the participants.</span></li></ul><ul class="c14 lst-kix_m7ug533nwn28-0"><li class="c7 c10"><span class="c0">9. Information and consent</span></li></ul><ul class="c14 lst-kix_m7ug533nwn28-1 start"><li class="c7 c16"><span class="c0">9.1 Will the research subjects be informed about the research project and be asked whether they want to participate or not?</span></li><li class="c7 c16"><span class="c0">9.1.2 Justify why the research subjects should not be informed and asked</span></li></ul><ul class="c14 lst-kix_m7ug533nwn28-0"><li class="c7 c10"><span class="c0">10. Register information</span></li></ul><ul class="c14 lst-kix_m7ug533nwn28-1 start"><li class="c7 c16"><span class="c0">10.1 Will the project request information from an existing register?</span></li></ul><ul class="c14 lst-kix_m7ug533nwn28-2 start"><li class="c7 c29"><span class="c0">10.1.2 What information will be requested and why? </span></li></ul><ul class="c14 lst-kix_m7ug533nwn28-0"><li class="c7 c10"><span class="c0">13. Presentation of results</span></li></ul><ul class="c14 lst-kix_m7ug533nwn28-1 start"><li class="c7 c16"><span class="c0">13.1 How is access to data for the research leader and contributing researchers guaranteed?</span></li><li class="c7 c16"><span class="c0">13.2 Who is responsible for data processing and written reporting of the results?</span></li><li class="c7 c16"><span class="c0">13.3 How and when are the results planned to be published?</span></li><li class="c7 c16"><span class="c0">13.4 How is the research subjects&#39; right to privacy guaranteed when the material is published?</span></li></ul><h3 class="c17" id="h.fhffb6cyzrnq"><span class="c11">Amounts of data</span></h3><p class="c7"><span class="c0">&quot;The statistical power determines the expected number of significant results and is related to the probability that a certain significant result reflects a true effect. In AREA we now know that if we increase the number of patients with N new cases, it will lead to U-V new significant findings. If we double the size of PREVIOUS_STUDY, then we should identify X-Y&#39;s new POSSIBLE_ CAUSES of DISEASE, which would make an important contribution with new knowledge of the underlying etiology behind DISEASE.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;The number of images that will be extracted is related to the power and relevance referred to per study and we wish to be able to make a high quality randomized selection, which is why the number BIG_NUMBER images includes a margin based on the digital 5 year production now existing in the digital archive (a total of approximately MUCH_BIGGER_NUMBER).&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Today many place their trust in the fact that various support systems based on artificial intelligence (AI) will be able to offer AREA help both to streamline and improve the quality of the work of PROFESSIONALS. One challenge in this context is that the training data needed to develop AI systems for these purposes are greatly limited, if at all available. This project aims to develop and publish an open image database containing detailed annotations for training of AI systems to support imaging diagnostics by PROFESSIONALS in connection to diagnosis and follow-up of patients in AREA. &quot;</span></p><h3 class="c17" id="h.e57qzfkanu2l"><span class="c11">Risk minimization </span></h3><h4 class="c25" id="h.15d0rtrlckol"><span class="c26">Confidentiality</span></h4><p class="c7"><span class="c0">&quot;All new employees at RESEARCH_INSTITUTION sign agreements on non-disclosure and confidentiality.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Personnel who come into contact with data provide written assurances that they in no context will breach confidentiality provisions.&quot;</span></p><h4 class="c25" id="h.qs4spcfvr7o8"><span class="c26">Responsibility and competence</span></h4><p class="c7"><span class="c0">&quot;NAMED_ RESEARCHER, ROLE at RESEARCH_INSTITUTION, is responsible for the safety of the research subjects, which in this project means that resources are available to manage the project according to plan with regard to anonymization and security etc. See certificate in ANNEX.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;The research is carried out under the responsibility of the head of the DEPARTMENT, RESEARCH_INSTITUTION. The DEPARTMENT has the necessary resources and expertise to ensure the safety and integrity of the research subjects (data confidentiality) and the implementation of the research project, see ANNEX&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>&quot;The integrity of the participants is protected on the basis of a structured information security work in accordance with ISO 27000. This means that the work is guided by policies, guidelines and staff awareness.&quot;</span></p><h4 class="c25" id="h.7tuzijxm8i6s"><span class="c26">Access restrictions</span></h4><p class="c7"><span class="c0">&quot;No unauthorized person has access to the premises (access card and code) where data and materials are stored. Special access rights apply to DEPARTMENT premises. &quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;No data is stored locally. All data is stored centrally in a server room at RESEARCH_INSTITUTION. The server room is protected according to common standards for perimeter protection. All connections to the central server room are encrypted.&quot;</span></p><h4 class="c25" id="h.9jp564v8dj5m"><span class="c26">Limitation to less sensitive data types</span></h4><p class="c7"><span>&quot;Data describing the working methods of PROFESSIONALS will be collected. These will only be available to researchers in the project and will only be published in anonymous form.&quot;</span></p><h4 class="c25" id="h.509smevwfdbf"><span class="c26">Limitation to only data</span></h4><p class="c7"><span class="c0">&quot;No deviations from clinical routine or regular treatment will occur within the project.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Regarding past experiences of the treatment used: &quot;Not relevant, as the project will not directly lead to any change or addition to patient care.&quot;</span></p><h4 class="c25" id="h.z581szqivo61"><span class="c26">Participation in multiple projects</span></h4><p class="c7"><span class="c0">&quot;Because our study is observational and not an intervention study, the research subjects are not at increased risk if this observational study is combined with another research study.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Several studies can utilize data from the project, but the research subjects are not affected by this because these studies do not entail renewed contact with the participants.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Not relevant. The research subjects are not at risk by being part of this project, so combination effects with other projects will not occur.&quot;</span></p><h4 class="c25" id="h.jrpc573v0rsp"><span class="c26">Technology</span></h4><p class="c7"><span class="c0">&quot;Encryption keys are sent separately and with an independent transfer method.&quot;</span></p><h3 class="c17" id="h.yg5m7zj2gakk"><span class="c11">Linked data from several sources</span></h3><p class="c7"><span class="c0">&quot;Data will be sent with social security numbers from DATA_SOURCES and linked, after which data will be pseudonymized.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Social security numbers must be retained during the data collection part of the study, after which the images and the entire database will be pseudonymized.&quot;</span></p><h3 class="c17" id="h.30gszmslsd72"><span class="c11">Pseudonymous data</span></h3><p class="c7"><span class="c0">&quot;All data will be pseudonymized and given random code numbers which cannot be linked to individual identities. The key linking codes to individuals will be stored only at the RESEARCH_INSTITUTION.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;The data is stored such that individuals are not identifiable other than by the research team.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Written documents are stored locked and with code numbers.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Database information is linked to code numbers and cannot reveal individual identities.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;The results are compiled in tables where no individual can be identified.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Pseudonymous data SPECIFICATION will be stored in DATABASE or similar within EU / EEA and in accordance with GDPR. Data in this database will be used and analyzed by research groups in Sweden and abroad. To access data, researchers must then apply for data to be disclosed, therein describing how data will be used (which must be in line with this application). &quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Security is guaranteed by participant login with e-identification (BankID) and using secure protocols (https).&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Unidentified data will be analyzed by responsible researchers as well as contributing researchers.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;The pseudonymization key will be encrypted and stored at HUVUDMAN, accessible only to senior management in the research project. The associated encryption key will be stored locked in safes at HUVUDMAN. Data in pseudonymous form will be processed and shared on systems intended for processing sensitive personal data for research in compliance with GDPR, and will be stored to enable research validation. Pseudonymous data that is no longer needed will be anonymized or deleted. Data in anonymous form will be published and shared to enable further research.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Data in pseudonymous form will be processed and shared on local IT systems according to HUVUDMAN&#39;s routines, and on national systems specially designed for processing sensitive personal data for research purposes in accordance with GDPR, such as SNIC-SENS Bianca.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;If other researchers want to review the data and reproduce the results, they will be offered access to pseudonymous or anonymous data under non-disclosure agreements, either on site at HUVUDMAN or using national systems specifically designed for processing sensitive personal data for research in accordance with GDPR.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;When presenting results, these will be unidentified, and if individual results are presented, they will not be linked to identifiable information. The results will mainly be reported at an aggregated level.&quot;</span></p><h3 class="c17" id="h.8r419tfng12h"><span class="c11">Anonymous data</span></h3><p class="c7"><span class="c0">&quot;Patients are not informed about the research project. The applicant researchers conclude that this is not needed, since personal data is not processed.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Consent is not obtained from the patients. The applicant researchers conclude that this is not needed, since personal data is not processed.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;The project does not subject participants to risk. The patients are not affected by the project.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;The project brings no direct benefit to the research subjects. Patients are not affected by the project. Professional participants will not benefit directly, but may in the future benefit from results in the form of improved tools and working methods.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;No ethical problems. Hopefully, research can indirectly lead to improved future care.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Regarding the data subjects&#39; right to privacy: &quot;Not relevant to patients. Personal data from patients will never be processed in research because the first step is full anonymization.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;The collection and de-identification will be done through a semi-automatic procedure. An authorized person will manage the collection within the hospital network. Thereafter, de-identification will be done automatically, whereupon data will be stored, under password protection, and then made available to researchers in the project. The applicant researchers draw the conclusion that this approach means that the data processed in the project, though originally collected from patients, does not constitute personal data in the sense of the law or is sensitive to integrity, and is thus not affected by ethical review. &quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;The application mainly applies to data collected at the clinic for medical reasons, regardless of the research study. The project does not handle personal data from patients, ie data cannot be traced back to the data subjects. Thus, the project can not affect patients in any way, and therefore does not affect their security.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Data will be de-identified in such a way that the information cannot be traced back to the individual from which it originated. Information such as name, social security number and telephone number will be removed or replaced with generated data. Indirectly identifying information, such as referral and examination numbers will also be removed or replaced. &quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Data is extracted from the clinical IT system through an automatic procedure. An automated program will handle this within the hospital network, including all anonymization. Data will then be stored anonymously. Anonymized image data will then be enriched with medical metadata, especially in the form of annotations by medical experts on various tissue types and disease manifestations. &quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Anonymized data is intended to be published and made available to other researchers in the field to provide the opportunity for reproduction of the study and thereby increase the validity of the method, and also to provide the opportunity for their own research in, for example, the development of image analysis applications.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;Data protection is not relevant, as the project does not handle personal data from patients or sensitive information about participating professionals.&quot;</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">&quot;All researchers have access to data and will all contribute to data processing and publications, under the supervision of the named competent researcher.&quot;</span></p><hr style="page-break-before:always;display:none;"><p class="c3"><span class="c0"></span></p><hr style="page-break-before:always;display:none;"><h1 class="c8" id="h.y634q6va22h"><span class="c27"></span></h1><h1 class="c19" id="h.g7csyqb0s5h5"><span>Appendix 3 </span><span class="c27"><br>Examples of anonymization in medical imaging</span></h1><p class="c7"><span class="c0">This document contains examples of what AIDA considers correct anonymization along with rationale, to support researchers trying to choose appropriate anonymization methods for their own datasets. The intention is for this document to evolve in open discussions over time, with the purpose of establishing a national common view on anonymization in medical imaging, which has the potential to greatly facilitate medical imaging research in Sweden and beyond.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>As we learned in the section </span><span class="c9"><a class="c2" href="#h.jqg9p3qlo7q">Protective measures</a></span><span>&nbsp;in Appendix 1, GDPR does not require absolute certainties -which is often difficult or impossible to establish- but appropriate measures relative to the risk. The AIDA stance on appropriate measures is described and motivated in the AIDA GDPR policy 1.0 section </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://docs.google.com/document/d/1TvjTeoUiqaafnBQGaJDjHcFCUBfhiKmUTWJG_bkGIWs/edit%23heading%3Dh.i639kmr8va6o&amp;sa=D&amp;ust=1576784592227000">Definition of anonymous data</a></span><span class="c0">. Essentially, this states that thoughtful anonymization is an appropriate protective measure for using clinical imaging data in research. This statement is not controversial, but supported by a veritable mountain of evidence in the form of images that are regularly and continually published openly in scientific journals as part of good clinical research practice. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">What then is appropriate anonymization in medical imaging? </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>While we have concluded several times already (cf for example </span><span class="c9"><a class="c2" href="#h.yj4ewpf0zyau">here</a></span><span class="c0">) that this question must in each case be finally answered by the researchers themselves, we can provide a few examples of what AIDA considers correct anonymization, to support researchers trying to make thoughtful decisions regarding their own datasets.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>Each case below has been deemed appropriately anonymous for </span><span class="c9"><a class="c2" href="#h.hlxrehmxegqn">AIDA data hub sharing</a></span><span>, with select images published openly as examples on the </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://datasets.aida.medtech4health.se/&amp;sa=D&amp;ust=1576784592229000">AIDA dataset register</a></span><span class="c0">.</span></p><h2 class="c13" id="h.am9tnqromcqb"><span class="c18">General guidelines</span></h2><p class="c7"><span class="c0">While anonymization must always be assessed on a case-by-case basis, we can condense a few guidelines based on links and examples available in this section.</span></p><h3 class="c17" id="h.1zhfi8ui0l70"><span class="c11">Associated information</span></h3><p class="c7"><span>Even in cases where an image is inarguably anonymous, it may still be potentially sensitive information and identifiable through its associated data, like diagnosis, lab analysis data, time stamps, patient age and sex and so on. This is discussed in the section on </span><span class="c9"><a class="c2" href="#h.ehd2n2d80dvr">Informational protective measures</a></span><span>.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">These combinations of data types can be anonymous (depending on specific circumstances which must be evaluated on a case-by-case basis):</span></p><p class="c3"><span class="c0"></span></p><ol class="c14 lst-kix_jtd3tbs1bw4z-0 start" start="1"><li class="c7 c10"><span class="c6">Images.</span><span class="c0">&nbsp;</span></li><li class="c7 c10"><span class="c6">Images + scanner model.</span><span class="c0"><br>Even if the caregiver might be identified by the combination of scanners.</span></li><li class="c7 c10"><span class="c6">Images + scanner model + time period.</span><span class="c0"><br>Even if examinations were likely carried out in the interval between scanner model launch date and dataset creation date.</span></li><li class="c7 c10"><span class="c6">Images + scanner model + time period + examination type.</span><span class="c0"><br>Even if the image data is from an identifiable request type with a well defined examination protocol.</span></li><li class="c7 c10"><span class="c6">Images + scanner model + time period + examination type + diagnosis.</span><span class="c0"><br>Even if a low percentage may be found positive/negative in this type of examination.</span></li><li class="c7 c10"><span class="c6">Even further characterizing data</span><span><br>But you must motivate your </span><span>decision</span><span>&nbsp;yourself</span><span class="c0">!</span></li></ol><h3 class="c17" id="h.gi6nk6rt1ay1"><span>Anonymization </span><span class="c11">measures for clinical imaging data</span></h3><p class="c7"><span class="c0">In the clinical PACS, the pixel data is stored together with large amounts of related information as structured elements in the extensive and very expressive DICOM format. Many of these elements may contain identifying information. It can be nontrivial to know which need to be removed or modified in order to ensure proper anonymization. Different approaches are differently effective for different datasets, so for each case one should strive to select a method that is satisfactory in terms of anonymization while still not negatively impacting the ability to carry out the planned research. For large scale anonymization it is good practice to use automated tools to do most of the work, and to iteratively review the output and tweak the parameters, until no more identifying information is found in the results. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Elements to remove:</span></p><ul class="c14 lst-kix_9pa7v49w8h61-0 start"><li class="c7 c10"><span class="c0">Response: remove number, names and initials (pat and doc), HSAID.</span></li><li class="c7 c10"><span class="c0">Images: remove scanned images, images with unknown source, or images with low intensity variance (usually these are pictures of text, which may contain identifiable information).</span></li></ul><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">Elements to modify:</span></p><ul class="c14 lst-kix_9pa7v49w8h61-0"><li class="c7 c10"><span class="c0">Times: initial additive timeshift, and proportional timeshifts of inter-examination interval.</span></li></ul><h2 class="c13" id="h.fkapetemf4d8"><span class="c18">Computed Tomography Pulmonary Angiography (CTPA) data</span></h2><p class="c7"><span>Dataset: </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://datasets.aida.medtech4health.se/10.23698/aida/ctpa&amp;sa=D&amp;ust=1576784592236000">https://doi.org/10.23698/aida/ctpa</a></span></p><p class="c7"><span class="c0">Example images:</span></p><p class="c7"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.50px; height: 108.88px;"><img alt="" src="images/image1.jpg" style="width: 145.18px; height: 108.88px; margin-left: -0.34px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.50px; height: 108.88px;"><img alt="" src="images/image4.jpg" style="width: 145.18px; height: 108.88px; margin-left: -0.34px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.50px; height: 108.88px;"><img alt="" src="images/image7.jpg" style="width: 145.18px; height: 108.88px; margin-left: -0.34px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c7"><span class="c32">30 clinical routine CTPA examinations, performed on a Philips Brilliance 64 CT or GE Lightspeed VCT. 14317 axial images (1 or 0,625mm) plus additional reformats. 5 of the CTPAs are positive for pulmonary embolism and have all the emboli carefully delineated by an experienced radiologist.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">These CTPA image stacks were originally obtained in clinical routine examinations to provide care for patients. They were then extracted from the clinical PACS for research purposes and anonymized at the clinic using a programmable hardware module configured for this purpose and set up as a teleradiology destination onsite at the clinic. &nbsp;AIDA has developed software tools that work similarly.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">In the clinical PACS, the pixel data is stored together with large amounts of related information as structured elements in the extensive and very expressive DICOM format. This data was anonymized by carefully deleting or modifying elements using automated tools, and reviewing the results afterwards for unexpected findings. Different methods are differently effective for different datasets, and several automated methods were evaluated before a method was found that was deemed adequate for this dataset, while still being feasible at scale and producing useful output for research. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">For example, one of the methods that was deemed insufficient left very accurate timestamps for the examinations in the supposedly anonymized data, which together with other easily deduced properties from the dataset (eg: caregiver) and image data (eg: gender) could make reidentification by a lay person or motivated intruder plausible. In contrast, the chosen method allowed timeshifting the examinations by an arbitrary number of days, making the examinations chronologically consistent for each patient, but making their identities harder to deduce.</span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span>The fine tuning of the anonymization method nevertheless required multiple iterations of automated filtering and manual review to identify and mitigate all elements with potentially identifying information. This also had to be repeated for each scanner, as different instrument manufacturers tend to favor different types of elements for their recording of the same types of information. Notably, several elements were found to contain very accurate examination timestamps, and some images (such as the </span><span>radiation dose report</span><span>) contained </span><span>burned-in</span><span class="c0">&nbsp;patient information and thus could not be included in the export. </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">When full review of all exported DICOM data no longer revealed any plausibly identifying information for pilot cases, the configuration was deemed fit for export at scale. When exporting at scale, one examination out of every 100 were again selected for complete review of all exported DICOM data, to confirm the validity of the method, and to verify that no new types of potentially identifying information was now being added to the allowed elements (eg by clinical staff or otherwise). </span></p><p class="c3"><span class="c0"></span></p><p class="c7"><span class="c0">It is reasonable to expect that every combination of caregiver and instrument manufacturer will have their own &quot;house rules&quot; for how DICOM elements are used, so it is recommended that anyone involved in anonymization carry out this type of full review of exported DICOM data, to establish which elements are safe to disclose and which aren&#39;t, in relation to other information available on the dataset.</span></p><h2 class="c13" id="h.9uaduxcj7iyv"><span class="c18">Skeletal data from the Visual Sweden project DROID</span></h2><p class="c7"><span>Dataset: </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://datasets.aida.medtech4health.se/10.23698/aida/drske&amp;sa=D&amp;ust=1576784592241000">https://doi.org/10.23698/aida/drske</a></span></p><p class="c7"><span class="c0">Example images:</span></p><p class="c7"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.50px; height: 108.88px;"><img alt="" src="images/image11.png" style="width: 144.50px; height: 108.88px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.50px; height: 108.88px;"><img alt="" src="images/image5.png" style="width: 145.18px; height: 108.88px; margin-left: -0.34px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.50px; height: 108.88px;"><img alt="" src="images/image6.png" style="width: 145.18px; height: 108.88px; margin-left: -0.34px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.50px; height: 108.88px;"><img alt="" src="images/image10.png" style="width: 145.18px; height: 108.88px; margin-left: -0.34px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c7"><span class="c36">36 annotated radiology cases showing lytic and lytic/sclerotic (blastic) metastases i.e. bone regenerative and degenerative.</span><span class="c0">&nbsp;</span></p><p class="c3"><span class="c0"></span></p><ul class="c14 lst-kix_bxaiij9jxv4a-0 start"><li class="c7 c10"><span class="c0">Data was anonymized at the caregiver before disclosure.</span></li><li class="c7 c10"><span class="c0">Data was collected retrospectively from routine clinical practice, representing a small part of the total number of similar examinations carried out at the caregiver.</span></li><li class="c7 c10"><span class="c0">Data was extracted in an automatic process, where a computer program extracted the data and removed identifying information such as name, personal identification number and telephone number, or replaced it with generated information. Indirectly identifying information such as request- and examination numbers was also removed or replaced.</span></li><li class="c7 c10"><span class="c0">Data was inspected visually by medical staff before disclosure, to ensure no identifying features were present in the data.</span></li><li class="c7 c10"><span class="c0">This procedure was described in the (approved) research ethical review application, which also described the intent to publish and share data thusly anonymized for the purposes of research validation and as a basis for further research and AI tool development.</span></li></ul><h2 class="c13" id="h.cyo9t71vzsdg"><span class="c18">Axillary lymph nodes in breast cancer cases</span></h2><p class="c7"><span>Dataset: </span><span class="c9"><a class="c2" href="https://www.google.com/url?q=https://datasets.aida.medtech4health.se/10.23698/aida/brln&amp;sa=D&amp;ust=1576784592244000">https://doi.org/10.23698/aida/brln</a></span></p><p class="c7"><span class="c0">Example images:</span></p><p class="c7"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.50px; height: 108.88px;"><img alt="" src="images/image3.jpg" style="width: 145.18px; height: 108.88px; margin-left: -0.34px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.50px; height: 108.88px;"><img alt="" src="images/image9.jpg" style="width: 145.18px; height: 108.88px; margin-left: -0.34px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.50px; height: 108.88px;"><img alt="" src="images/image2.jpg" style="width: 145.18px; height: 108.88px; margin-left: -0.34px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 144.50px; height: 108.88px;"><img alt="" src="images/image8.jpg" style="width: 145.18px; height: 108.88px; margin-left: -0.34px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c7"><span class="c32">Whole slide imaging of 396 full cases of axillary lymph nodes in breast cancer cases. Included are both sentinel node surgery and axillary resections pre, peri or post breast cancer surgery or treatment. Sentinel node cases are cut in three levels (stained with HE) and one additional slide immunohistochemically stained with CKAE1/AE3. The number of sentinel node cases with complete immunohistochemical staining is 321. The axillary resections are cut with one cut level as default. Included are both positive and negative cases.</span></p><p class="c3"><span class="c0"></span></p><ul class="c14 lst-kix_bxaiij9jxv4a-0"><li class="c7 c10"><span class="c0">Data was anonymized at the caregiver before disclosure.</span></li><li class="c7 c10"><span class="c0">Data was collected retrospectively from routine clinical practice, representing a small part of the total number of similar examinations carried out at the caregiver.</span></li><li class="c7 c10"><span>Case data was extracted manually from the laboratory information system. Corresponding image data was extracted from the PACS in an automatic process, where a computer program also removed identifying information such as name, personal identification number and telephone number, or replaced it with generated information. Indirectly identifying information such as request- and examination numbers was also removed or replaced. Time stamps were removed and the order of examinations was randomized</span><span>.</span></li><li class="c7 c10"><span class="c0">Data was inspected visually by medical staff before disclosure, to ensure no identifying features were present in the data.</span></li><li class="c7 c10"><span class="c0">This procedure was described in the (approved) research ethical review application, which also described the intent to publish and share data thusly anonymized for the purposes of research validation and as a basis for further research and AI tool development.</span></li></ul><p class="c3"><span class="c0"></span></p><div class="c35"><p class="c34"><a href="#cmnt_ref1" id="cmnt1">[a]</a><span class="c0">Delete in January.</span></p></div><div class="c35"><p class="c34"><a href="#cmnt_ref2" id="cmnt2">[b]</a><span class="c0">Delete in January.</span></p></div></body></html>